Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1307 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A¥â1−42 and C-terminal fragment of APP directly induces release of cytochromec C from isolated mouse brain mitochondria Kim, Hye-Sun
2000
21 S1 p. 253-
1 p.
artikel
2 Aβ42 and tau as markers in early AD Blennow, Kaj
2000
21 S1 p. 4-
1 p.
artikel
3 Aβ as a homeostatic negative regulator of synaptic function? Kamenetz, Flavio
2000
21 S1 p. 76-77
2 p.
artikel
4 Aberrant tau splicing caused by mutations associated with inherited dementia Wu, Jane
2000
21 S1 p. 59-
1 p.
artikel
5 Abnormal conditions in AD brain may modulate LRP-mediated catabolism of Aβand APP Moir, Robert D.
2000
21 S1 p. 259-
1 p.
artikel
6 Abnormal hyperphosphorylation of non-tau proteins in Alzheimer's disease brain Vijayan, Shrijay
2000
21 S1 p. 150-
1 p.
artikel
7 Abnormality of corticogenesis by pulse exposure of aluminum maltol to fetal ‘knock-in’ mice with the 1213T presenilin-1 missense mutation Fukusho, Eriko
2000
21 S1 p. 152-
1 p.
artikel
8 A brief neuropsychological battery for the early diagnosis of Alzheimer's disease Abrisqueta-Gomez, Jacqueline
2000
21 S1 p. 95-
1 p.
artikel
9 Absence of cell surface presenilin 1 in HEK293 and MDCK cells Tandon, Anurag
2000
21 S1 p. 115-
1 p.
artikel
10 Absence of presenilin 1 expression enhances β-catenin/LEF signaling independently of notch-1 Soriano, Salvador
2000
21 S1 p. 67-
1 p.
artikel
11 Acalculia: Deficits of operational and non-operational number knowledge Crutch, Sebastian J.
2000
21 S1 p. 159-
1 p.
artikel
12 Acalculia in Alzheimer's disease and other dementias — patterns of deterioration Kalbe, Elke
2000
21 S1 p. 231-
1 p.
artikel
13 Accelerated Aβ generation in AD models of lysosomal system upregulation Mathews, Paul M.
2000
21 S1 p. 206-
1 p.
artikel
14 Accelerated β amyloid nucleation by oxidatively damaged lipid membranes Koppaka, Vishwanath
2000
21 S1 p. 9-
1 p.
artikel
15 Accessing health care finance administration beneficiaries as potential participants in a primary prevention trial for Alzheimer's disease Costa, Rosann
2000
21 S1 p. 92-
1 p.
artikel
16 Accumulation of Aβ in transgenic mice Prior, Peter Paul
2000
21 S1 p. 88-
1 p.
artikel
17 Accumulation of amyloid β protein in the detergent-insoluble membrane compartment Kawarabayashi, Takeshi
2000
21 S1 p. 198-199
2 p.
artikel
18 Accumulation of intracellular amyloid ß peptide in Alzheimer's disease Bjors, Jenny
2000
21 S1 p. 200-
1 p.
artikel
19 A central executive deficit in short-term maintenance of visuospatial information in early senile dementia of the Alzheimer-type Dalrymple-Alford, John C.
2000
21 S1 p. 82-
1 p.
artikel
20 Acetylcholinesterase inhibition, learning, and nicotinic receptors Woodruff-Pak, Diana S.
2000
21 S1 p. 165-
1 p.
artikel
21 A clinical algorithm for 14-3-3 testing in Creutzfeldt-Jakob disease Lemstra, Afina W.
2000
21 S1 p. 97-
1 p.
artikel
22 A comparison of co-morbid diseases between African-Americans and white probable Alzheimers disease patients Harrell, Lindy E.
2000
21 S1 p. 91-
1 p.
artikel
23 A correlative study of volume measurement MRI of limbic system with clinical scale examination in dementia of Alzheimer's type Zhang, Hong-Yan
2000
21 S1 p. 252-
1 p.
artikel
24 A critical comparison of hippocampal and global rates of atrophy in Alzheimer's disease Scahill, Rachael I.
2000
21 S1 p. 130-131
2 p.
artikel
25 Activation of P38 kinase links π phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease Zhu, Xiongwei
2000
21 S1 p. 267-
1 p.
artikel
26 Activity of stabilized vegetable extracts against oxidative stress and beta amyloid toxicity Govoni, Stefano
2000
21 S1 p. 111-
1 p.
artikel
27 Acupuncture enhancement in clinical symptoms and cognitive-motor abilities of the Alzheimer's disease patients Kao, Henry S.R.
2000
21 S1 p. 79-
1 p.
artikel
28 Acupuncture to treat anxiety and depression in Alzheimer's disease and vascular dementia: A pilot feasibility and effectiveness trial Emerson Lombardo, Nancy B.
2000
21 S1 p. 29-
1 p.
artikel
29 Acute changes in Alzheimer's disease-related markers after human head trauma DeKosky, Steven T.
2000
21 S1 p. 84-
1 p.
artikel
30 A cyclic peptide antagonistic to the 75kD neurotrophin receptor protects neurons from beta amyloid induced cell death Yaar, Mina
2000
21 S1 p. 184-
1 p.
artikel
31 A decamer duplication in the BRI gene originates a de-novo amyloid peptide that causes dementia in a Danish kindred Vidal, Ruben G.
2000
21 S1 p. 58-
1 p.
artikel
32 A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic Fezoui, Youcef
2000
21 S1 p. 77-
1 p.
artikel
33 Aβ deposition in vascular myocytes cultured from APP transgenic mouse: The role of cell lipid oxidation Frackowiak, Janusz
2000
21 S1 p. 185-
1 p.
artikel
34 Aβ42 deposition is selectively altered in brains of Aβ1–42 immunized TG2576 mice Das, Pritam
2000
21 S1 p. 152-153
2 p.
artikel
35 A differential memory profile in patients with subjective memory complaints and normal MMSE score: Depression or cognitive decline? Kulisevsky, Jaime
2000
21 S1 p. 157-
1 p.
artikel
36 A full genome scan for late onset Alzheimers disease Owen, Michael
2000
21 S1 p. 138-
1 p.
artikel
37 Age and gender as risk modifiers of ApoE-ϵ4 in Alzheimer's disease Small, Brent J.
2000
21 S1 p. 247-
1 p.
artikel
38 Age and gender-specific effects of a myeloperoxidase promoter polymorphism in Alzheimer's disease Morris, Mark
2000
21 S1 p. 249-
1 p.
artikel
39 Age associated memory impairment in rodents Gallagher, Michela
2000
21 S1 p. 71-
1 p.
artikel
40 Age at natural menopause and risk of dementia: The Rotterdam study Geerlings, Mirjam I.
2000
21 S1 p. 101-
1 p.
artikel
41 Age-dependent deficit in late-phase LTP in the hippocampus of human APP695SWE X PS1A246E double transgenic mice Kuenzi, Frederick M.
2000
21 S1 p. 125-
1 p.
artikel
42 A genetic linkage study on late-onset familial Alzheimer's disease does not provide strong evidence for linkage to chromosome 1Q22, 9Q21.1, 10Q23, and chromosome 11Q23.3 Rogaeva, Ekaterina A.
2000
21 S1 p. 103-
1 p.
artikel
43 A genome-wide search for novel early-onset Alzheimer disease genes Cruts, Marc
2000
21 S1 p. 128-
1 p.
artikel
44 Age-related loss of calcium binding proteins may predispose basal forebrain cholinergic neurons to degeneration in Alzheimer's disease Wu, Chuang-Kuo
2000
21 S1 p. 121-
1 p.
artikel
45 Age-related memory deficits in doubly transgenic mice correlate with amyloid burden Morgan, Dave
2000
21 S1 p. 18-
1 p.
artikel
46 Age-related pathological, neurochemical and behavioural changes in transgenic TG(HUI.APP.695.SWE)2576 mice Bednar, Ivan
2000
21 S1 p. 226-
1 p.
artikel
47 Age specific risk of dementia according to gender, education and wine consumption Dartigues, Jean-Francois
2000
21 S1 p. 64-
1 p.
artikel
48 Age-transformation of hippocampal volumes improves diagnostic accuracy in Alzheimer's disease Teipel, Stefan J.
2000
21 S1 p. 106-
1 p.
artikel
49 Aging increases amyloid peptides and causes plaques in brain of old APP/London transgenic mice by a different mechanism than a mutant presenilin-1 transgene Dewachter, Ilse
2000
21 S1 p. 20-
1 p.
artikel
50 Aging in the brain: Evolutionary perspectives Finch, Caleb E.
2000
21 S1 p. 280-
1 p.
artikel
51 Aging, oxidative stress, molecular chaperones, and Alzheimer's disease Goldgaber, Dmitry
2000
21 S1 p. 186-
1 p.
artikel
52 Aging-related cyclization of aspartate as the initial event in amyloid formation Orpiszewski, Jozef
2000
21 S1 p. 145-
1 p.
artikel
53 Agrin and microvascular damage in Alzheimer's disease Berzin, Tyler M.
2000
21 S1 p. 53-
1 p.
artikel
54 A high fat diet during adulthood increases risk for Alzheimer's disease for those with the APOE-ϵ4 allele Petot, Grace J.
2000
21 S1 p. 246-
1 p.
artikel
55 Alcohol consumption and risk of dementia: Results from the Rotterdam study Ruitenberg, Annemieke
2000
21 S1 p. 247-
1 p.
artikel
56 Alfa-D-mannosidases in patients with familial Alzheimer's disease Orlacchio, Antonio
2000
21 S1 p. 16-
1 p.
artikel
57 Allele frequency distribution of alpha-2 macroglobulin V1000I and insertion-deletion polymorphisms in Alzheimer's disease patients Mesa, Maria Dolores
2000
21 S1 p. 250-
1 p.
artikel
58 A longitudinal study of dimension of caregiver burden in Alzheimer's disease Trabucchi, Marco Mt.
2000
21 S1 p. 276-
1 p.
artikel
59 Alteration of glutathione metabolism and abnormal calcium accumulation in the mitochondria of hamster brain infected with scrapie agent Lee, Hyoung-gon
2000
21 S1 p. 151-
1 p.
artikel
60 Alteration of vasopressin mRNA expression in the suprachiasmatic nucleus of the patients with Alzheimer disease Liu, Rong-Yu
2000
21 S1 p. 54-
1 p.
artikel
61 Altered brain perfusion in patients with mild to moderate Alzheimer's Disease does not necessarily involve temporarietal neocortex Paulesu, Eraldo
2000
21 S1 p. 108-
1 p.
artikel
62 Altered IP3-dependent intracellular Ca2+ pools of hippocampal neurons in presenilin-1 mutant transgenic mice Wolfgang Herms, Jochen
2000
21 S1 p. 225-
1 p.
artikel
63 Aluminum exposure affects mitochondrial gene expression in PC12 cells Bosetti, Francesca
2000
21 S1 p. 262-
1 p.
artikel
64 Alzheimer disease (AD) and inclusion-body myositis (IBM) ; Do the remarkable cytochemical similarities indicate similarities of molecular pathogenesis? Askanas, Valerie
2000
21 S1 p. 206-207
2 p.
artikel
65 Alzheimer disease and rivastigmine treatment Herrero, Fernando A.
2000
21 S1 p. 91-
1 p.
artikel
66 Alzheimer-like neurodegeneration in aged anti-nerve growth factor transgenic mice Capsoni, Simona
2000
21 S1 p. 85-
1 p.
artikel
67 Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity: Role of methionine residue 35 and CU(II) and prevention by vitamin E Butterfield, Allan
2000
21 S1 p. 188-189
2 p.
artikel
68 Alzheimer's disease as a preteolytic disorder and implications for devising therapy Saido, Takaomi C.
2000
21 S1 p. 137-
1 p.
artikel
69 Alzheimer's disease in a genetically isolated population: The grip study Roks, Gerwin
2000
21 S1 p. 177-
1 p.
artikel
70 Alzheimer's disease in male veterans: Prevalence and risk factors Hengge, Xie
2000
21 S1 p. 33-
1 p.
artikel
71 Alzheimer's disease in the NAS-NRC Registry of aging veteran twins Plassman, Brenda L.
2000
21 S1 p. 80-
1 p.
artikel
72 Alzheimer's disease management from the patients point of view Norberg, Astrid
2000
21 S1 p. 75-
1 p.
artikel
73 Alzheimer's disease patients display a pro-inflammatory cytokine profile Bollen, Eduard Lem
2000
21 S1 p. 231-
1 p.
artikel
74 Alzheimer's disease presenilin-1 regulates assembly of neurofilaments Dowjat, Wieslaw K.
2000
21 S1 p. 110-
1 p.
artikel
75 Alzheimer's plaques re-created in a test tube: Further insights into the mechanism of amyloid plaque formation Snow, Alan D.
2000
21 S1 p. 52-53
2 p.
artikel
76 Amino acid 384 of presenilin 1 is part of a putative active domain Steiner, Harold
2000
21 S1 p. 67-
1 p.
artikel
77 Amino acids in the beta-amyloid precursor protein YENP motif modulate endocytosis and cellular distribution Perez, Ruth G.
2000
21 S1 p. 184-
1 p.
artikel
78 Amnesic syndrome in a memory disorders clinic: A 1-year follow-up study Sjoe, Nina
2000
21 S1 p. 144-
1 p.
artikel
79 A model for investigators: Recruiting African-Americans in clinical research Parfitt, Francine C.
2000
21 S1 p. 93-
1 p.
artikel
80 Aβ-modulation: The next generation of ad therapeutics Molinoff, Perry B.
2000
21 S1 p. 136-
1 p.
artikel
81 A multidisciplinary memory clinic in a neurological setting: Structural neuroimaging in 704 consecutive patients Hasselbalch, Steen G.
2000
21 S1 p. 179-
1 p.
artikel
82 A multinational clinical trial of the effectiveness of a combined psychosocial and pharmacological intervention for AD patients and family caregivers Mittelman, Mary S.
2000
21 S1 p. 268-
1 p.
artikel
83 Amyloid AB (1–40) and AB(1–42) adopt remarkably stable, monomeric, and extended structures in water solution at neutral pH Zagorski, Michael Gerard
2000
21 S1 p. 10-11
2 p.
artikel
84 Amyloid Aβ40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia Andersen, Christian
2000
21 S1 p. 90-
1 p.
artikel
85 β-amyloid: An inert deposit comes alive Cotman, Carl W.
2000
21 S1 p. 134-
1 p.
artikel
86 Amyloid-beta is a lipoprotein-associated antioxidant which functions by chelating transition metal ions Kontush, Anatol
2000
21 S1 p. 49-
1 p.
artikel
87 Amyloid fibrils are stochastic assemblies of proteins linked together by a continuous β-sheet structure Makowski, Lee
2000
21 S1 p. 48-
1 p.
artikel
88 β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium : Usage of a novel blood brain barrier endothelial cell model system Davies, Theresa A.
2000
21 S1 p. 220-
1 p.
artikel
89 β-amyloid helps to protect neurons from oxidative stress Bishop, Glenda M.
2000
21 S1 p. 226-
1 p.
artikel
90 Amyloidogenic effects of α1-antichymotrypsin in vitro and in vivo Yamin, Rina
2000
21 S1 p. 260-
1 p.
artikel
91 β-Amyloid peptide does not bind iron after fixation but senile plaques do Dixon, Malia M.
2000
21 S1 p. 57-
1 p.
artikel
92 Amyloid-βpeptide insertion is critical for membrane induced fibril assembly: Implication for Aβ-induced neurotoxicity McLaurin, JoAnne
2000
21 S1 p. 109-
1 p.
artikel
93 β-amyloid plaques in amyloid precursor protein knock-in mice Popp, Andreas
2000
21 S1 p. 223-
1 p.
artikel
94 Amyloid precursor protein and amyloid-β-production are altered by caspase inhibition after traumatic brain injury in humanized Aβ mice Ciallella, John R.
2000
21 S1 p. 18-
1 p.
artikel
95 Amyloid precursor protein binding partners in human embryonic kidney 293 cells Ellenstein, Aviva
2000
21 S1 p. 260-
1 p.
artikel
96 Amyloid precursor protein in platelets of patients with Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors (donepezil) treatment Padovani, Alessandro
2000
21 S1 p. 166-167
2 p.
artikel
97 Amyloid precursor protein, microtubule associated protein tau, and ubiquinated inclusions: Brain and spinal cord pathology of various transgenic mice Oostveen, Jo A.
2000
21 S1 p. 122-
1 p.
artikel
98 β-amyloid precursor protein processing: Calreticulin as a molecular chaperone Johnson, Robin J.
2000
21 S1 p. 117-
1 p.
artikel
99 β-Amyloid priming and CD40L-mediated activation enhance cytokine and chemokine production in mononuclear phagocytes Cotter, Robin L.
2000
21 S1 p. 258-
1 p.
artikel
100 Amyloid protein precursor 63–73 peptide sequence is neurotrophic Sheng, Shu Li
2000
21 S1 p. 258-
1 p.
artikel
101 Amyloid protein precursor secretion by chick sympathetic neurons is inhibited by Aβ peptides Su San Mok,
2000
21 S1 p. 145-
1 p.
artikel
102 Amyloid-β stimulation of primary human macrophages results in CC-chemokine production Smits, Hessel A.
2000
21 S1 p. 262-
1 p.
artikel
103 Analysis of candidate genes of chromosome 12P Song, You-Qiang
2000
21 S1 p. 129-
1 p.
artikel
104 Analysis of cerebrospinal fluid beta-amyloid and apolipoprotein E lipoproteins in APPV717F transgenic mice DeMattos, Ronald B.
2000
21 S1 p. 86-
1 p.
artikel
105 Analysis of 1184 genes in Alzheimer CA1 hippocampus: Synaptic signaling and transcription factor deficits and upregulation of proinflammatory pathways Lukiw, Walter J.
2000
21 S1 p. 48-49
2 p.
artikel
106 Analysis of high-MR polymers of protein tau in the brain of transgenic mice overexpressing human tau4R Lasrado, Reena
2000
21 S1 p. 19-
1 p.
artikel
107 Analysis of mutation of the tau gene in Alzheimer's disease Urakami, Katsuya
2000
21 S1 p. 105-
1 p.
artikel
108 Analysis of the cell distribution of endogenous murine leukemia virus in the brains of SAMRI and SAMP8 mice Jeong, Byung-hoon
2000
21 S1 p. 17-
1 p.
artikel
109 Analysis of the functional role of endosomal presenilin-1 Lah, James J.
2000
21 S1 p. 48-
1 p.
artikel
110 Analysis of the role of charge residues in the transmembrane domains of presenilin-2 Reinhard, Friedrich B.M.
2000
21 S1 p. 112-
1 p.
artikel
111 An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a one-year, double-blind, randomized trial Wimo, Anders
2000
21 S1 p. 63-
1 p.
artikel
112 A neuroprotective role for telomerase in experimental models relevant to the pathogenesis of Alzheimer's disease Fu, W.
2000
21 S1 p. 44-45
2 p.
artikel
113 An evaluation of donepezil in Alzheimer's disease: Results from a post marketing surveillance study in Germany Calabrese, Pasquale
2000
21 S1 p. 277-
1 p.
artikel
114 A new family with Gerstmann-Straussler-Scheinker disease with a mutation of codon 232 (met to THR) Liberski, Powel P.
2000
21 S1 p. 122-
1 p.
artikel
115 A new genetic screening assay for gamma-secretase Fleur Sernee, M.
2000
21 S1 p. 144-
1 p.
artikel
116 A new molecular link between granulovacuolar and neurofibrillary lesions of Alzheimer's disease Kuret, Jeff
2000
21 S1 p. 191-
1 p.
artikel
117 A new 17 point memory test evaluating the treatment of patients with probable Alzheimer's disease in a busy primary care practice Gillie, Edward
2000
21 S1 p. 237-
1 p.
artikel
118 A new subtype of familial early onset Alzheimer's disease with coexisting β amyloid and prion pathology Leuba, Genevieve
2000
21 S1 p. 53-
1 p.
artikel
119 A new syndrome of dementia Ghiso, Jorge
2000
21 S1 p. 280-
1 p.
artikel
120 An exonic polymorphism of the cathepsin D gene is a major risk factor for Alzheimer's disease Papassotiropoulos, Andreas
2000
21 S1 p. 104-
1 p.
artikel
121 Angiotensin converting enzyme gene polymorphism in presenilin linked Alzheimer's disease families and sporadic acid Forleo, Paolo
2000
21 S1 p. 46-
1 p.
artikel
122 Angiotensin-converting-enzyme I/D polymorphism and angiotensinogen M235T polymorphism in dementia: A genetic study de Olano, Marta
2000
21 S1 p. 250-
1 p.
artikel
123 Angiotensin converting enzyme insertion/deletion polymorphism and Alzheimer disease risk in African Americans Evans, Rebecca M.
2000
21 S1 p. 36-
1 p.
artikel
124 An immunoelectron microscopy study of tau in six cases of frontotemporal dementia with Parkinsonism linked to chromosome 17 Davies, Yvonne
2000
21 S1 p. 190-191
2 p.
artikel
125 An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments Fezoui, Youcef
2000
21 S1 p. 77-
1 p.
artikel
126 An investigation of mechanisms to prevent the cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons in young rats Wenk, Gary L.
2000
21 S1 p. 226-
1 p.
artikel
127 An observational study of the effectiveness of donepezil in the treatment of Alzheimer's disease Jones, Kirsten E.
2000
21 S1 p. 160-
1 p.
artikel
128 A noetic nosogeny of ad Amoroso, Richard L.
2000
21 S1 p. 218-
1 p.
artikel
129 Anosognosia in Alzheimer disease Montanes, Patricia
2000
21 S1 p. 143-
1 p.
artikel
130 A novel approach to Alzheimer's disease treatment: Intranasal application of neuroprotective peptide fragments Gozes, Illana
2000
21 S1 p. 169-
1 p.
artikel
131 A novel isoform of acetylcholinesterase (ACHEAD) in cerebrospinal fluid is a potential diagnostic marker for Alzheimer disease that is not altered in other neurological diseases Saez-Valero, Javier
2000
21 S1 p. 272-
1 p.
artikel
132 A novel missense mutation (L219F) in exon 8 of the presenilin 1 gene in an italian family with presenile familial Alzheimer's disease Terreni, Liana
2000
21 S1 p. 176-177
2 p.
artikel
133 Anti-amyloid approaches to treating Alzheimer's disease DeKosky, Steven T.
2000
21 S1 p. 8-
1 p.
artikel
134 Anti-amyloidogenic activity of tetracyclines: In vitro studies Forloni, Gianluigi
2000
21 S1 p. 242-
1 p.
artikel
135 A phosphatidylcholine precursor ameliorates age-related changes in the mouse hippocampus Fernandez-Viadero, Carlos
2000
21 S1 p. 121-
1 p.
artikel
136 A pilot trial of propranolol for disruptive agitation in Alzheimer's disease Peskind, Elaine R.
2000
21 S1 p. 232-
1 p.
artikel
137 APOE4 allele frequency in frontotemporal lobar degeneration Short, Rodney A.
2000
21 S1 p. 123-
1 p.
artikel
138 Apo E and apo E receptor gene expression in the brain of Alzheimer's disease subjects with different apoE genotype Dea, Doris
2000
21 S1 p. 115-
1 p.
artikel
139 APOE and estrogen in mouse models of Alzheimer disease Smith, Jonathan D.
2000
21 S1 p. 139-
1 p.
artikel
140 APOE 3 4 and 4 4 genotypes are important risk factors for Alzheimer's disease in African Americans Graff-Radford, Neill R.
2000
21 S1 p. 158-
1 p.
artikel
141 APOE and lipid profiles in probable and possible AD patients versus controls in Bogotá (Colombia) Torres, Orlando
2000
21 S1 p. 162-
1 p.
artikel
142 APOE as therapeutic target for the treatment of Alzheimer's disease Poirier, Judes
2000
21 S1 p. 139-
1 p.
artikel
143 APOE: Biology and biochemistry Weisgraber, Karl H.
2000
21 S1 p. 138-
1 p.
artikel
144 APOE E4 is associated with rapid cognitive decline in Alzheimer's disease Holker, Erin G.
2000
21 S1 p. 156-
1 p.
artikel
145 APOE genotype and environmental factors predict when - not if - one is predisposed to develop Alzheimer's disease Breitner, John C.S.
2000
21 S1 p. 211-
1 p.
artikel
146 ApoE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease Aerssens, Jeroen
2000
21 S1 p. 177-
1 p.
artikel
147 APOE genotype, vascular risk and cognitive impairment in an African Caribbean population Stewart, Robert
2000
21 S1 p. 34-
1 p.
artikel
148 APOE ϵ4 is not a significant risk factor for AD in Nigerian Africans Ogunniyi, Adesola O.
2000
21 S1 p. 100-
1 p.
artikel
149 APOE polymorphisms in Alzheimer's disease Chartier-Harlin, Marie-Christine
2000
21 S1 p. 137-
1 p.
artikel
150 Apolipoprotein D distribution in normal and Alzheimer's brains: Implications for its role in the pathogenesis of Alzheimer's disease Ikonomovic, Milos D.
2000
21 S1 p. 82-
1 p.
artikel
151 Apolipoprotein E allele frequency in African vs African Americans Willis, Floyd B.
2000
21 S1 p. 38-39
2 p.
artikel
152 Apolipoprotein E ε4 allele is associated with atrophy of the amygdala in Alzheimer's disease van Dyck, Christopher H.
2000
21 S1 p. 39-
1 p.
artikel
153 Apolipoprotein E, amyloid beta 40 and 42, and cognitive function in aging and Alzheimer's disease Schneider, Julie A.
2000
21 S1 p. 120-
1 p.
artikel
154 Apolipoprotein E, amyloid deposition and Alzheimer's disease: Therapeutic implications 2000
21 S1 p. 9-
1 p.
artikel
155 Apolipoprotein E and its receptors mediate the effects of β-amyloid-induced inflammation in primary astrocyte cultures LaDu, Mary Jo
2000
21 S1 p. 148-149
2 p.
artikel
156 Apolipoprotein E and longevity in a sample of colombian population Pinzon, Jorge
2000
21 S1 p. 176-
1 p.
artikel
157 Apolipoprotein E ε4 and stroke are independent risk factors of cognitive decline: Results from a population-based study Dik, Miranda G.
2000
21 S1 p. 35-
1 p.
artikel
158 Apolipoprotein E and the risk for Alzheimer's disease in Italians: An epidemiological study in over 1000 patients Casadei, Valeria M.
2000
21 S1 p. 250-251
2 p.
artikel
159 Apolipoprotein E-ε4 as a risk factor for Alzheimer and non-Alzheimer'sdementias: Findings from the nun study Mortimer, James A.
2000
21 S1 p. 32-33
2 p.
artikel
160 Apolipoprotein E gene status and neuropsychological test performance in a population-based sample of elderly Canadians Klages, Jennifer D.
2000
21 S1 p. 248-
1 p.
artikel
161 Apolipoprotein E genotype and brain white matter fractional anisotropy in the elderly Crandall, David T.
2000
21 S1 p. 251-
1 p.
artikel
162 Apolipoprotein E genotype as a predictor of progression from cognitively impaired, but not demented to dementia over a 5-year period Sadovnick, Dessa
2000
21 S1 p. 37-
1 p.
artikel
163 Apolipoprotein E genotype does not influence course of cognitive decline in mild cognitive impairment and Alzheimer's disease Arnaiz, Eva
2000
21 S1 p. 231-
1 p.
artikel
164 Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer disease Arboleda, Gonzalo H.
2000
21 S1 p. 105-
1 p.
artikel
165 Apolipoprotein E levels in patients with probable Alzheimer S disease are affected by paraoxonase polymorphisms Pedrini, Steve
2000
21 S1 p. 156-
1 p.
artikel
166 Apolipoprotein E modulates processing of vitamin E in brain Vatassery, Govind T.
2000
21 S1 p. 258-
1 p.
artikel
167 Apolipoprotein E polymorphism, total cholesterol and Alzheimer's disease in prevalent and incident cases in Chile Albala, Cecilia
2000
21 S1 p. 172-
1 p.
artikel
168 Apoptotic cascades in synaptic terminals: Roles for Par-4, BCL-2 family members and P53 in mitochondrial dysfunction Duan, W.
2000
21 S1 p. 43-
1 p.
artikel
169 A population-based study of family history in relation to dementia and apolipoprotein E polymorphism in 85-year-olds Tengelin, Elisabeth G.
2000
21 S1 p. 99-
1 p.
artikel
170 A population-based study of the association between cerebral white matter lesions and cognitive functions Dufouil, Carole
2000
21 S1 p. 247-
1 p.
artikel
171 A possible mechanism for nicotinic acetylcholine receptor deficit in Alzheimer brain—lipid peroxidation and distructure of biological cellular mambrane Guan, Zhi-Zhong
2000
21 S1 p. 188-
1 p.
artikel
172 A possible vaccine for treatment of Alzheimer's disease Schenk, Dale B.
2000
21 S1 p. 134-
1 p.
artikel
173 APP and notch proteolysis by γ-secretase requires that these substrates complex with PS1 Ray, William J.
2000
21 S1 p. 184-
1 p.
artikel
174 APP and PS-1 transgenic mice Borchelt, David R.
2000
21 S1 p. 76-
1 p.
artikel
175 APP and tau phosphorylation in early Alzheimer's disease Davies, Peter
2000
21 S1 p. 210-211
2 p.
artikel
176 Approaches to modeling hereditary Parkinson's disease in mice Gispert, Suzana
2000
21 S1 p. 134-135
2 p.
artikel
177 APP secretion is regulated by activation of PKC and tyrosine kinase in cultured human astrocytes Kim, Chul
2000
21 S1 p. 50-
1 p.
artikel
178 A practical method to predict rate of cognitive decline in mild to moderate Alzheimer's disease Matsui, Toshifumi
2000
21 S1 p. 39-
1 p.
artikel
179 A quantitative immunohistochemical analysis of Á-tubulin of basal cells in Alzheimer's disease and vascular dementia Xiao, Jihua
2000
21 S1 p. 236-237
2 p.
artikel
180 A randomized, placebo-controlled, double-blind, clinical trial of sertraline in the treatment of major depression complicating Alzheimer disease: Initial results from the diads study Lyketsos, Constantine George
2000
21 S1 p. 243-
1 p.
artikel
181 A rapid method to clone large PCR generated APP fragments Folkesson, Ronnie
2000
21 S1 p. 50-
1 p.
artikel
182 Are novel genes for early-onset Alzheimer's disease to be expected? Van Broeckhoven, Christine
2000
21 S1 p. 211-
1 p.
artikel
183 A role for integrin receptors in attenuating neuronal death Gary, D.S.
2000
21 S1 p. 47-
1 p.
artikel
184 A routinely applicable marker based on computed tomography sensitive to Alzheimer's disease and mild cognitive impairment: The radial width of the temporal horn Frisoni, Giovanni B.
2000
21 S1 p. 40-
1 p.
artikel
185 A second cytotoxic proteolytic peptide derived from β-amyloid precursor protein Lu, Daniel C.
2000
21 S1 p. 255-
1 p.
artikel
186 A simple method for detection of apolipoprotein E E4 allele Nakagawa, Yasushi
2000
21 S1 p. 165-
1 p.
artikel
187 A S52R mutation in neuroserpin is associated with myoclonic epilepsy and dementia Yazaki, Masahide
2000
21 S1 p. 66-
1 p.
artikel
188 Assessment of emotional memory in patients with Alzheimer's disease Abrisqueta-Gomez, Jacqueline
2000
21 S1 p. 162-
1 p.
artikel
189 Association between diffuse amyloid β deposits and glial cells in hereditary cerebral hemorrhage with amyloidosis-dutch type Maat-Schieman, Marion L.C.
2000
21 S1 p. 78-
1 p.
artikel
190 Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease Sorbi, Sandro
2000
21 S1 p. 148-
1 p.
artikel
191 Association between presenilin-1 mutation Glu318Gly and complaints of memory impairment among non-demented subjects Laws, Simon M.
2000
21 S1 p. 105-
1 p.
artikel
192 Association of a polymorphism of the prion protein gene with age at onset and rate of cognitive decline in Alzheimer's disease Casadei, Valeria M.
2000
21 S1 p. 176-
1 p.
artikel
193 Association of cystatin C with amyloid-βprotein Calero, Miguel
2000
21 S1 p. 118-
1 p.
artikel
194 Association of PSI with GSK-3β Takashima, Akihiko
2000
21 S1 p. 5-
1 p.
artikel
195 Association of the TNF-α C-850T polymorphism with vascular dementia in Northern Ireland McIlroy, Stephen P.
2000
21 S1 p. 205-
1 p.
artikel
196 Association strategies in Alzheimer's disease: Findings from the NIMH genetics initiative Blacker, Deborah
2000
21 S1 p. 137-
1 p.
artikel
197 Association studies of novel polymorphisms in BACE and BACE2 Nowotny, Petra
2000
21 S1 p. 102-103
2 p.
artikel
198 Association study between a promoter polymorphism in the presenilin 1 gene and late-onset Alzheimer's disease Dermaut, Bart
2000
21 S1 p. 177-
1 p.
artikel
199 Aβ starts to deposit on cell surface plasma membrane in diffuse plaques Yamaguchi, Haruyasu
2000
21 S1 p. 56-
1 p.
artikel
200 A study of diffusion-weighted (DWI) and magnetization transfer imaging (MTI) in patients with Alzheimer's disease (AD) Franceschi, Massimo
2000
21 S1 p. 96-
1 p.
artikel
201 A study on the catabolism and function of wild-type and mutated α-synucleins da Costa, Christine Alves
2000
21 S1 p. 235-
1 p.
artikel
202 A successful regional memory screening day for community dwelling elders Lawrence, Janet M.
2000
21 S1 p. 98-
1 p.
artikel
203 A tau PAC transgenic mouse that has developmentally appropriate and tissue specific expression of all six human tau isoforms Poorkaj, Parvoneh
2000
21 S1 p. 88-89
2 p.
artikel
204 Atherosclerotic-like changes of the wall of cerebral microvessels in transgenic mice overexpressing amyloid β Aliev, Gjumrakch
2000
21 S1 p. 267-
1 p.
artikel
205 A transgenic model of a familial prion disease Harris, David A.
2000
21 S1 p. 209-
1 p.
artikel
206 A truncated form of secreted amyloid precursor protein induces apoptosis of neurons in culture Wallace, William Charles
2000
21 S1 p. 260-
1 p.
artikel
207 A twist of the prism: Family & clinician measures of Alzheimer's disease treatment Graham, Janice E.
2000
21 S1 p. 91-
1 p.
artikel
208 A unifying hypothesis of alzheimer's disease Heininger, Kurt
2000
21 S1 p. 221-
1 p.
artikel
209 Author index 2000
21 S1 p. 287-304
18 p.
artikel
210 BACE and BACE2 define a novel subfamily of trans-membrane aspartic proteases Bennett, Brian D.
2000
21 S1 p. 112-
1 p.
artikel
211 BCL-2 family proteins in neuronal disease Hardwick, Jan M.
2000
21 S1 p. 282-
1 p.
artikel
212 BCL-2 protects against apoptosis-related microtubule alterations in neuronal cells: Implications for Alzheimer's disease Nuydens, Rony
2000
21 S1 p. 45-
1 p.
artikel
213 Behavioral impairment and dementia among the elderly population of the province of agrigento: An epidemiological survey performed by general practicioners Fioravanti, Mario
2000
21 S1 p. 238-
1 p.
artikel
214 Benefits of donepezil in the treatment of behavioral problems in moderate to severe Alzheimer's disease Hecker, Jane
2000
21 S1 p. 162-
1 p.
artikel
215 Benefits of donepezil on cognition, function and/or neuropsychiatric symptoms in patients with Alzheimer's disease over one year Waldemar, Gunhild
2000
21 S1 p. 274-
1 p.
artikel
216 Benefits of donepezil on performance of basic and instrumental activities of daily living in moderate to severe Alzheimer's disease Gauthier, Serge
2000
21 S1 p. 161-
1 p.
artikel
217 Biochemical characterization of γ-secretase activity that produces β-amyloid peptide Zhang, Lili
2000
21 S1 p. 52-
1 p.
artikel
218 Biochemical diagnosis of Alzheimer's disease Mulder, Cees
2000
21 S1 p. 21-
1 p.
artikel
219 Biochemistry and identity of γ-secretase Wolfe, Michael S.
2000
21 S1 p. 136-
1 p.
artikel
220 Biomarkers in predicting early in Alzheimer's disease Galasko, Douglas R.
2000
21 S1 p. 4-
1 p.
artikel
221 Biophysical and kinetic characterization of amyloid-βfibril elongation Wogulis, Mark D.
2000
21 S1 p. 11-
1 p.
artikel
222 Bleomycin hydrolase alters amyloid precursor protein trafficking, aβsecretion and the Aβ42/Aβ40 ratio in a dose dependent manner Abraham, Carmela R.
2000
21 S1 p. 260-
1 p.
artikel
223 Blink reflex changes in AD Iacono, Diego
2000
21 S1 p. 166-
1 p.
artikel
224 Body mass index and cognitive impairment: Results of the PAQUID study Deschamps, Valerie
2000
21 S1 p. 244-
1 p.
artikel
225 Brain functional imaging in early and preclinical Alzheimer's disease Nordberg, Agneta
2000
21 S1 p. 74-
1 p.
artikel
226 Brain region specific upregulation of apoliprotein E by estrogen in mice Levin, Justine A.
2000
21 S1 p. 151-
1 p.
artikel
227 BRI amyloid precursor protein isoforms. BRI2 is mutated in familial British dementia Vidal, Ruben G.
2000
21 S1 p. 13-
1 p.
artikel
228 Brush handwriting treatment of cognitive deficiencies in Alzheimer's disease patients Kao, Henry S.R.
2000
21 S1 p. 14-
1 p.
artikel
229 Calcium release from internal stores controls the direct association of AKT kinase with presenilin Haughey, N.J.
2000
21 S1 p. 86-
1 p.
artikel
230 Calpain-mediated P35 to P25 conversion is induced by neurotoxic processes and amyloid βtreatment Lee, Ming sum
2000
21 S1 p. 48-
1 p.
artikel
231 CaMKII-dependent phosphorylation of neurofilament-L is induced by visual stimulation of dark-reared rat Yu, Nakamura
2000
21 S1 p. 111-
1 p.
artikel
232 Candidate genes associated with Alzheimer's disease Farrer, Lindsay A.
2000
21 S1 p. 138-
1 p.
artikel
233 Candidate genes showing no evidence of association with Alzheimer disease — Results of the Nimh-Alzheimer disease genetics initiative Bertram, Lars
2000
21 S1 p. 129-
1 p.
artikel
234 Can proxies provide a valid report of everyday task performance for persons with Alzheimer's disease? Doble, Susan E.
2000
21 S1 p. 232-
1 p.
artikel
235 Can the EEG bispectral index detect neurological decline of Alzheimer's disease? Sigl, Jeffrey C.
2000
21 S1 p. 236-
1 p.
artikel
236 Can the interaction between apolipoprotein E (ApoE) genotype and gender be used to identify different dementias? MacGowan, Sian H.
2000
21 S1 p. 248-249
2 p.
artikel
237 Can we trust meta-analysis in dementia? Qizilbash, Nawab
2000
21 S1 p. 241-
1 p.
artikel
238 Cardiovascular risk factors and Alzheimer's disease: Genetic association studies in a population aged 85+ Myllykangas, Liisa
2000
21 S1 p. 175-
1 p.
artikel
239 Caspase-3 is activated in Alzheimer disease but not in frontotemporal dementia Marcon, Gabriella
2000
21 S1 p. 81-
1 p.
artikel
240 Caspase-mediated modulation of AMPA receptor function in response to DNA damage in hippocampal neurons: Implications for apoptosis in Alzheimer's disease Lu, C.
2000
21 S1 p. 44-
1 p.
artikel
241 Caspase-3 mediates apoptosis in Gerstmann-Sträussler-Scheinker (GSS) disease Migheli, Antonio
2000
21 S1 p. 266-
1 p.
artikel
242 Caspases, amyloid metabolism and Alzheimer's disease LeBlanc, Andrea C.
2000
21 S1 p. 136-137
2 p.
artikel
243 Catalase inhibits amyloid β-induced cell death in human brain pericytes in vitro Rensink, Annemieke A.M.
2000
21 S1 p. 108-
1 p.
artikel
244 Catalytic activity of 82 KDA choline acetyltransferase is regulated by protein kinase C Dobransky, Tomas
2000
21 S1 p. 181-
1 p.
artikel
245 Category: (B8) long term management of Alzheimer's disease presentation: Modifying functional decline Beck, Cornelia
2000
21 S1 p. 75-
1 p.
artikel
246 Cell biology of APP and PS1 Thinakaran, Gopal
2000
21 S1 p. 76-
1 p.
artikel
247 Cell cycle and chromosome segregation defects in alzheimer's disease Potter, Huntington Potter
2000
21 S1 p. 224-
1 p.
artikel
248 Cell death and neuroprotection in Parkinson's disease Olanow, Warren
2000
21 S1 p. 134-
1 p.
artikel
249 Cell-free system studies of proteolytic activities generating the Alzheimer's disease Aβ peptide C termini Bergman, Anna
2000
21 S1 p. 46-
1 p.
artikel
250 Cellular addiction receptors and their relationship to Alzheimer's disease Bredesen, Dale E.
2000
21 S1 p. 214-
1 p.
artikel
251 Cellular mechanisms of amylod accumulation & pathogenesis Glabe, Charles G.
2000
21 S1 p. 70-
1 p.
artikel
252 Cellular metabolism of familial British dementia-associated BRI-L Kim, Seong-Hun
2000
21 S1 p. 132-
1 p.
artikel
253 Cellular prion protein mediates laminin-dependent neurite outgrowth in primary cultures of rat and mouse hippocampal neurons Forlenza, Orestes V.
2000
21 S1 p. 52-
1 p.
artikel
254 Cerebral deposition of ABRI amyloid in familial British dementia Révész, Tamas
2000
21 S1 p. 191-
1 p.
artikel
255 Cerebral expression of APOE and apoc-I in Alzheimer's disease in relation to ϵ4 and H2 polymorphic alleles Petit-Turcotte, Caroline
2000
21 S1 p. 205-
1 p.
artikel
256 Cerebral hypoperfusion causes boundary zone cortical infarcts in Alzheimer's disease Suter, Oda-Christina
2000
21 S1 p. 54-55
2 p.
artikel
257 Cerebrolysin® improves memory performance and the brain bioelectrical activity pattern in elderly humans Lombardi, Valter
2000
21 S1 p. 167-
1 p.
artikel
258 Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease Schoenknecht, Peter
2000
21 S1 p. 28-29
2 p.
artikel
259 Cerebrospinal fluid tau in dementia disorders Shoji, Mikio
2000
21 S1 p. 228-
1 p.
artikel
260 Cerebrospinal fluid tau protein phosphorylated at threonine 231 in Alzheimer's disease patients, healthy controls and subjects at risk Buerger, Katharina
2000
21 S1 p. 22-
1 p.
artikel
261 Cerebrovascular disease and dementia: Clinical pathological correlation Gustafson, Lars
2000
21 S1 p. 7-
1 p.
artikel
262 Cerebrovascular risk factors, brain morphology and cognitive decline DeCarli, Charles
2000
21 S1 p. 142-
1 p.
artikel
263 Changes in cognitive characteristics of TG APP CRND8 mice at early stages of immunization with beta amyloid peptide Janus, Christopher George
2000
21 S1 p. 61-
1 p.
artikel
264 Changes in neuronal nicotinic receptor subtypes in transgenic mice and in human subjects carrying the Swedish APP 670 671 mutation Marutle, Amelia M
2000
21 S1 p. 153-
1 p.
artikel
265 Characterisation of two novel aspartyl proteases as β-secretases Hussain, Ishrut
2000
21 S1 p. 223-
1 p.
artikel
266 Characteristics of dementia patients and spouse caregivers Maddox, Melitta K.
2000
21 S1 p. 146-147
2 p.
artikel
267 Characterization of Alzheimer's β-secretase protein bace: A pepsin family member with unusual properties Haniu, Mitsuru
2000
21 S1 p. 278-
1 p.
artikel
268 Characterization of amyloid deposits in the cerebral cortex of transgenic mouse expressing human APP6955SSWE: Implications for the pathogenesis of Alzheimer's disease Terai, Kazuhiro
2000
21 S1 p. 225-
1 p.
artikel
269 Characterization of amyloid precursor protein carboxy-terminal fragments in Alzheimer disease and Down's syndrome Russo, Claudio
2000
21 S1 p. 56-
1 p.
artikel
270 Characterization of channel formation by Alzheimer's β-amyloid protein: Inhibition by estradiol Kawahara, Masahiro
2000
21 S1 p. 52-
1 p.
artikel
271 Characterization of different transgenic mouse lines, overexpressing the FAD-linked human presenilin 1 CDNA Sturchler-Pierrat, Christine
2000
21 S1 p. 226-
1 p.
artikel
272 Characterization of the binding interaction between Aβ and heparin/heparan sulphate Davidson, Christopher M.
2000
21 S1 p. 51-
1 p.
artikel
273 Characterization of the presenilin associated protein, neural plakophilin-related armadillo protein (NPRAP) Yang, Dun-Sheng
2000
21 S1 p. 256-
1 p.
artikel
274 Charge alterations of E22 enhance the pathogenic properties of the amyloid-β protein Melchor, Jerry P.
2000
21 S1 p. 11-
1 p.
artikel
275 Chemical characterization of appican's chondrotin sulfate glycosaminoglycan chains Shioi, Junichi
2000
21 S1 p. 183-
1 p.
artikel
276 Childhood rural residence is a risk factor for incident Alzheimer's disease in African Americans Hall, Kathleen S.
2000
21 S1 p. 245-
1 p.
artikel
277 Cholesterol as well as Aβ induces vasoconstruction by stimulating a similar pro-inflammatory pathway Townsend, Kirk
2000
21 S1 p. 180-
1 p.
artikel
278 Cholesterol upregulates production of Aβ 1–40 and 1–42 in transfected cells Austen, Brian M.
2000
21 S1 p. 254-
1 p.
artikel
279 Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients Pappas, Bruce A.
2000
21 S1 p. 156-
1 p.
artikel
280 Cholinergic and neurotrophic markers within the nucleus basalis in elderly individuals with mild cognitive impairment and early Alzheimer's disease Mufson, Elliott J.
2000
21 S1 p. 270-271
2 p.
artikel
281 Cholinesterase inhibitors: Benefits and limitations Doody, Rachelle S.
2000
21 S1 p. 8-
1 p.
artikel
282 Cholinesterase inhibitors may exacerbate hypotensive episodes related to neurocardiovascular instability in people with dementia Kenny, Rose Anne
2000
21 S1 p. 77-
1 p.
artikel
283 Chracterization of inducible transfectants expressing mutated tau identified in FTDP-17 De Ture, Michael A.
2000
21 S1 p. 113-
1 p.
artikel
284 Chronic in vivo sodium azide infusion induces learning deficit and inhibition of choline-acetyl-transfertase Zhang, Lan
2000
21 S1 p. 152-
1 p.
artikel
285 Cingulate cortex reduction in muscarinic receptors in mild Alzheimer's disease demonstrated with I-123 iodo-dexetimide neuroreceptor spect Boundy, Karyn L.
2000
21 S1 p. 131-
1 p.
artikel
286 Circadian rhythm disturbances in advanced dementia: Diagnostic specicity Harper, David G.
2000
21 S1 p. 157-
1 p.
artikel
287 Cis- and trans-acting elements controlling alternative splicing of tau exon 10 Grover, Andrew
2000
21 S1 p. 218-219
2 p.
artikel
288 Citicoline exerts antiapoptotic effects in an animal model of hippocampal neurodegeneration Cacabelos, Ramon
2000
21 S1 p. 87-
1 p.
artikel
289 Clearance of endogenous soluble Aβ in neuronal and glial cultures Rebeck, G.William
2000
21 S1 p. 257-
1 p.
artikel
290 Clinical and brain biopsy findings in possible idiopathic normal-pressure hydrocephalus Bech, Rachid A.
2000
21 S1 p. 217-
1 p.
artikel
291 Clinical and imaging characteristics of vascular dementia in a memory clinic Pasquier, Florence
2000
21 S1 p. 127-
1 p.
artikel
292 Clinical and neuroanatomical correlates of the mirror sign in frontotemporal dementia and alzheimer's disease Caixeta, Leonardo Ferreira
2000
21 S1 p. 217-
1 p.
artikel
293 Clinical and neuropathological features of a family with hereditary frontotemporal dementia without tau mutations Rosso, Sonia M.
2000
21 S1 p. 146-
1 p.
artikel
294 Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer's disease (AD) and Parkinson's disease (PD): A comparative study Seltzer, Benjamin
2000
21 S1 p. 23-
1 p.
artikel
295 Clinical and neuropsychological features of aging which predict early Alzheimer's disease 2000
21 S1 p. 3-
1 p.
artikel
296 Clinical and neuropsychological features of neurodegenerative disorders in the Chamorro population of Guam Salmon, David P.
2000
21 S1 p. 124-
1 p.
artikel
297 Clinical and pathologic features of early and pre-clinical Alzheimer's disease (AD) Bennett, David A.
2000
21 S1 p. 74-
1 p.
artikel
298 Clinical characteristics in a family with early-onset Alzheimer disease caused by a mutation (V717L) in the APP gene Hake, Ann M.
2000
21 S1 p. 59-
1 p.
artikel
299 Clinical characterization of variant Alzheimer's disease with spastic paraparesis Verkkoniemi, Auli
2000
21 S1 p. 234-
1 p.
artikel
300 Clinical features in a kindred with familial frontotemporal dementia with the P301L tau mutation Boeve, Bradley F.
2000
21 S1 p. 79-
1 p.
artikel
301 Clinical features of familial frontotemporal dementia Bird, Thomas D.
2000
21 S1 p. 284-
1 p.
artikel
302 Clinical review of non-cholinergic therapies Rockwood, Kenneth
2000
21 S1 p. 8-
1 p.
artikel
303 Clinicopathological data on the progression of Alzheimer disease lesions in the cerebral cortex Duyckaerts, Charles
2000
21 S1 p. 265-
1 p.
artikel
304 CLN3 protein, a lysosomal-associated membrane protein, affects intracellular processing of APP and PS1 Golabek, Adam A.
2000
21 S1 p. 207-
1 p.
artikel
305 CNS biomarkers for Alzheimer's disease Growdon, John H.
2000
21 S1 p. 208-
1 p.
artikel
306 Codeposition of cystatin C with amyloid-ß protein in the brain of Alzheimer's disease patients Pawlik, Monika
2000
21 S1 p. 194-
1 p.
artikel
307 Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations Rosso, Sonia M.
2000
21 S1 p. 266-
1 p.
artikel
308 Cognitive and behavioral aspects of normal pressure hydrocephalus Boksay, Istvan
2000
21 S1 p. 24-
1 p.
artikel
309 Cognitive and behavioral improvements in aged primate microcebus murinus following one year treatment with the M1 muscarinic agonist, AF150(S) Fisher, Abraham
2000
21 S1 p. 19-
1 p.
artikel
310 Cognitive and biological correlates of response to donepezil in Alzheimer's disease Chertkow, Howard Mark
2000
21 S1 p. 24-
1 p.
artikel
311 Cognitive decline is not normal in old age Haan, Mary N.
2000
21 S1 p. 281-
1 p.
artikel
312 Cognitive deficits and atrophy in specific cortical regions in Alzheimer's disease: A 3D quantitated magnetic resonance study Acion, Laura
2000
21 S1 p. 106-
1 p.
artikel
313 Cognitive deficits in APOE4 transgenic mice and their relationship to aging, sex, and increased aβlevels Mucke, Lennart
2000
21 S1 p. 139-
1 p.
artikel
314 Cognitive function and frontal lobe atrophy is affected by education in normal aging: Implications for dementia as ‘age-related’ disorders and the reserve hypothesis Meguro, Kenichi
2000
21 S1 p. 99-
1 p.
artikel
315 Cognitive functioning and dementia prevalence in older latinos: Cardiovascular and cultural correlates Haan, Mary N.
2000
21 S1 p. 35-
1 p.
artikel
316 Cognitive function in the oldest old: Women perform better than men van Exel, Eric
2000
21 S1 p. 102-
1 p.
artikel
317 Cognitive rehabilitation combined to drug treatment in patients with Alzheimer's disease: Preliminary results Bottino, Cassio M.C.
2000
21 S1 p. 268-269
2 p.
artikel
318 Coherence between regional sources of brain electrical activity in Alzheimer's disease Jelic, Vesna
2000
21 S1 p. 10-
1 p.
artikel
319 Collagen deposition in an experimental model of brain damage and brain sections from patients with Alzheimers disease Peterson, Theresa C.
2000
21 S1 p. 98-
1 p.
artikel
320 Combination of cerebrospinal fluid tau, Aβ40 and Aβ42 analyses in the diagnosis of Alzheimer's disease Tapiola, Tero
2000
21 S1 p. 90-
1 p.
artikel
321 Combination of mini-mental-state-exam and clock drawing test leads to an enhanced sensitivity in screening for dementia Peters, Jurgen
2000
21 S1 p. 237-
1 p.
artikel
322 Common polymorphism in the α-1-antichymotrypsin and interleukin-1β genes increased the risk of alzheimer's disease Licastro, Federico
2000
21 S1 p. 205-
1 p.
artikel
323 Communicating about health and memory with dementia and non-dementia patients Sauners, Pamela A.
2000
21 S1 p. 13-
1 p.
artikel
324 Comparative study on clinical scale assessment between Alzheimer's disease, vascular dementia and normal aging Wang, Hua-Li
2000
21 S1 p. 163-
1 p.
artikel
325 Comparing two programs of cognitive training in mild to moderate Alzheimer disease (AD) Farina, Elisabetta
2000
21 S1 p. 196-
1 p.
artikel
326 Comparison of health utilization data with clinical assessment for evidence of dementia Tyas, Suzanne L.
2000
21 S1 p. 202-
1 p.
artikel
327 Comparison of the aggregation and fibrillogenesis of ABRI peptides Gordon, David J.
2000
21 S1 p. 83-
1 p.
artikel
328 Comparison of vascular risk factors between cohorts of the Indianapolis-Ibadan dementia study Ogunniyi, Adesola O.
2000
21 S1 p. 172-173
2 p.
artikel
329 Competitive regulation of aβredox activity by copper and zinc: Parallels in the pathogenetic mechanisms of Alzheimer's disease and familial amyotrophic lateral sclerosis Cuajungco, Math P.
2000
21 S1 p. 62-
1 p.
artikel
330 Components of the WNT signalling cascade affect APP metabolism Chapman, Sara C.
2000
21 S1 p. 270-
1 p.
artikel
331 Computer assisted trial design to support dose selection for CI-1017 in phase 2 Alzheimers studies Lockwood, Peter A.
2000
21 S1 p. 168-
1 p.
artikel
332 Conflicts of interest Clark, Chris M.
2000
21 S1 p. 6-
1 p.
artikel
333 Conformation and toxicity of the ABRI peptide in familial British dementia Ma El-Agnaf, Omar
2000
21 S1 p. 110-
1 p.
artikel
334 Contribution of APOE as a risk factor for Alzheimer's disease in iceland Jonsson, Thorlakur
2000
21 S1 p. 36-
1 p.
artikel
335 Control of transcription of the presenilin 1 gene by ETS transcription factors Pastorcic, Martine G.
2000
21 S1 p. 45-
1 p.
artikel
336 Correlation between Aβ42 deposition and clinical demetia Parvathy, Saravanapavan
2000
21 S1 p. 193-
1 p.
artikel
337 Correlation of platelet amyloid precursor protein ratios and declining cognition in Alzheimer's disease: A new severity index Baskin, Fred
2000
21 S1 p. 164-
1 p.
artikel
338 Correlations between hippocampal atrophy and neocortical glucose utilization in Alzheimer's disease: Mapping by SNPM Meguro, Kenichi
2000
21 S1 p. 81-
1 p.
artikel
339 Correlations between serum cholesterol parameters and plasma amyloid β protein Arvanitakis, Zoe
2000
21 S1 p. 96-
1 p.
artikel
340 Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies Estrella, Gomez-Tortosa
2000
21 S1 p. 54-
1 p.
artikel
341 Cost of care for patients with dementia in a medicare HMO setting Alagiakrishnan, Kannayiram
2000
21 S1 p. 146-
1 p.
artikel
342 Cost savings from decreased utilization of antipsychotic drugs associated with rivastigmine use in long term care facilities Mends, Patrick
2000
21 S1 p. 167-
1 p.
artikel
343 COX-2 dependent cell cycle activities in brains: Implications in the clinical progression of Alzheimer's disease dementia Mirjany, Mana
2000
21 S1 p. 180-
1 p.
artikel
344 C1Q and inflammation in Down syndrome pathogenesis Head, Elizabeth
2000
21 S1 p. 12-
1 p.
artikel
345 Cross cultural studies of dementia Hendrie, Hugh C.
2000
21 S1 p. 214-
1 p.
artikel
346 Cross-national comparisons of the ADAS and CAMDEX: The european harmonisation project of instruments for dementia (euro-harpid) Verheij, Frans Rj.
2000
21 S1 p. 173-
1 p.
artikel
347 CSF-phospho-tau as a promising marker for discriminating Alzheimer disease from Lewy body dementia Vanmechelen, Eugeen J.M.
2000
21 S1 p. 272-
1 p.
artikel
348 CSF tau and Aβ correlate with a clinical diagnosis of Alzheimer's disease Margolin, Richard A.
2000
21 S1 p. 22-
1 p.
artikel
349 CSF tau and beta amyloid may predict conversion from MCI to dementia Kurz, Alexander F.
2000
21 S1 p. 97-
1 p.
artikel
350 Cyclooxygenase expression in microglia and neurons in Alzheimer's disease brain Hoozemans, Jeroen Jm.
2000
21 S1 p. 119-
1 p.
artikel
351 Cyclosporin A prevents cytochrome C release in al-treated aged rabbit brain Ghribi, Othman
2000
21 S1 p. 154-
1 p.
artikel
352 Cytokines and Alzheimer's disease Griffin, Sue T.
2000
21 S1 p. 286-
1 p.
artikel
353 Cytokines stimulate primary human astrocytes to produce amyloid beta Blasko, Imrich
2000
21 S1 p. 114-
1 p.
artikel
354 Death, institutionalization, and progression to dementia in a population-based cohort of elderly Canadians: Comparing the influence of neuropsychological test performance and traditional dementia criteria, on outcome Fisk, John D.
2000
21 S1 p. 245-
1 p.
artikel
355 Decision-making-focused education as a mediator of family caregiving stress Narayan, Suzanne M.
2000
21 S1 p. 269-
1 p.
artikel
356 Decline of language among women and men with Alzheimer's disease Hebert, Liesi E.
2000
21 S1 p. 34-
1 p.
artikel
357 Decreased autocrine release of insulin-like growth factor-I (IGF-I) from immune cells is influenced by Aβ 1–42 fragment and is associated with reduced brain volume in subjects with Alzheimer's disease (AD) Solerte, Sebastiano B.
2000
21 S1 p. 266-
1 p.
artikel
358 Deficits of visuospatial attention ability in patients with alzheimer's disease as shown by posner paradigm Ishizaki, Junichi
2000
21 S1 p. 221-
1 p.
artikel
359 Defined target symptoms: Qualitatively describing treated Alzheimer's disease progression Bassett, Raewyn
2000
21 S1 p. 123-
1 p.
artikel
360 Delayed neurite extension in primary hippocampal cultures from tau knockout mice Dawson, Dawson N.
2000
21 S1 p. 88-
1 p.
artikel
361 Delivery of diagnostic proteins into the nervous system: Targeting of Alzheimer's amyloid plaques with polyamine-modified Aβ40 in APP, PS1 transgenic mice Poduslo, Joseph F.
2000
21 S1 p. 131-
1 p.
artikel
362 Delusions in AD are associated with right greater than left atrophy in the temporal lobes and with the opposite pattern in the frontal lobes Geroldi, Cristina
2000
21 S1 p. 201-
1 p.
artikel
363 Dementia care in Maracaibo, Venezuela Pino-Ramirez, Gloria
2000
21 S1 p. 195-
1 p.
artikel
364 Dementia severity and the magnitude of cognitive benefit by memantine treatment. A subgroup analysis of two placebo-controlled clinical trials in vascular dementia Sahin, Kurtulus
2000
21 S1 p. 27-
1 p.
artikel
365 2880 dementia with lewy bodies McKeith, Ian G.
2000
21 S1 p. 208-
1 p.
artikel
366 Dementia with Lewy bodies: Frequency in a community-based autopsy series and accuracy of the clinical diagnostic criteria Apaydin, Hulya
2000
21 S1 p. 124-
1 p.
artikel
367 Demtect: A new screening instrument for supporting diagnosis of dementia Kessler, Josef
2000
21 S1 p. 30-
1 p.
artikel
368 Denaturation improves the abilities of some globular proteins to inhibit Aβ fibrillogenesis O'Nuallain, Brian
2000
21 S1 p. 77-
1 p.
artikel
369 Dephosphorylation of tau protein induced by neuropsychiatric drugs Tanaka, Toshihisa
2000
21 S1 p. 47-
1 p.
artikel
370 Depression in persons with dementia in the first year after admission to a long term care facility Payne, Jennifer L.
2000
21 S1 p. 235-
1 p.
artikel
371 Depression symptoms associated with cognitive impairment: Is it really depression? Gleason, Carey E.
2000
21 S1 p. 237-
1 p.
artikel
372 Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease Galasko, Douglas R.
2000
21 S1 p. 168-
1 p.
artikel
373 Detection of amyloid β-peptide — methodological considerations Engvall, Benita
2000
21 S1 p. 237-
1 p.
artikel
374 Detection of amyloid with antibodies obtained by immunization of rabbits with fibrillar synthetic Aβ1-42 Wegiel, Jezy
2000
21 S1 p. 120-121
2 p.
artikel
375 Detection of early dementia syndrome of Alzheimer type in epidemiological and clinical samples Reischies, Friedel M.
2000
21 S1 p. 33-
1 p.
artikel
376 Detection of intraneouronal oligomers of the amyloid β-protein 2000
21 S1 p. 11-
1 p.
artikel
377 Detection of oligomeric β-amyloid peptide in biological samples using a singlesite monoclonal antibody sandwich enzyme-linked immunoabsorbant assay Watson, M.Desiree
2000
21 S1 p. 90-
1 p.
artikel
378 Detection of tau phosphorylated at theonine 231 in human brain extracts and cerebrospinal fluid Kohnken, Russell E.
2000
21 S1 p. 165-
1 p.
artikel
379 Detection of treatment responses in an anti-dementia drug trial using goal attainment scaling Fay, Sherri
2000
21 S1 p. 95-
1 p.
artikel
380 Deteriorated language function of Japanese and Portuguese of ‘bilingual’ alzheimer's disease: A trans-cultural study of elderly Japanese immigrants in Brazil Meguro, Kenichi
2000
21 S1 p. 222-
1 p.
artikel
381 Deterioration of attentional processes and instrumental activities of daily living as predictors of dementia Fabrigoule, Colette
2000
21 S1 p. 244-
1 p.
artikel
382 Determinants of survival of patients with Alzheimer disease: The role of disability and severity of cognitive impairment Pettenati, Carla
2000
21 S1 p. 245-
1 p.
artikel
383 Determination of the amino-terminal cleavage site of PRPRES in GSS F198S Piccardo, Pedro
2000
21 S1 p. 268-
1 p.
artikel
384 Development of a culture fair test for anomia in Alzheimer's disease Tappen, Ruth M.
2000
21 S1 p. 98-
1 p.
artikel
385 Development of an ELISA to quantitate soluble oligomers of Aß Austen, Brian M.
2000
21 S1 p. 199-
1 p.
artikel
386 Development of an ultrasensitive elisa-double enzyme amplification assay and quantitation of total and abnormally hyperphosphorylated taus in cerebrospinal fluid He, Shanshu
2000
21 S1 p. 228-
1 p.
artikel
387 Development of a scale to predict decline among mildly demented Alzheimer's disease patients Santillan, Concepcion G.
2000
21 S1 p. 93-
1 p.
artikel
388 Diabetes mellitus and the incidence of dementia in the Canadian study of health and aging MacKnight, Chris
2000
21 S1 p. 171-
1 p.
artikel
389 Dietary anti-oxidants and the risk of dementia. The Rotterdam study Engelhart, Marianne J.
2000
21 S1 p. 203-
1 p.
artikel
390 Dietary intake of vitamin E and vitamin C and cognitive decline in a biracial community population, ∗MC Morris, DA Evans, JL Bienias, RS Wilson and CC Tangney (Rush-Presbyterian-St. Luke S Medical Center, Chicago, IL, 60612) Morris, Martha Clare
2000
21 S1 p. 202-
1 p.
artikel
391 Dietary restriction and 2-deoxyglucose enhance synaptic glucose and glutamate transport and protect against synaptic dysfunction in experimental models of Alzheimer's disease Guo, Z.
2000
21 S1 p. 44-
1 p.
artikel
392 Diet-induced hyperlipidemia accelerates amyloid deposition in APPv717F transgenic mouse model of Alzheimer disease Bales, Kelly R.
2000
21 S1 p. 139-
1 p.
artikel
393 Differences in wandering by age, sex, race, and medical basis of dementia Algase, Donna L.
2000
21 S1 p. 96-
1 p.
artikel
394 Differential effects of cytosolic apolipoprotein (APO) E3 and APOE4 on neurite outgrowth and the cytoskeleton Huang, Yadong
2000
21 S1 p. 216-
1 p.
artikel
395 Differential expression of bax and BCL-2 in the brains of hamsters infected with 263K scrapie agent Park, Sang-Koo
2000
21 S1 p. 152-
1 p.
artikel
396 Differential expression of mRNAs detected by cDNA microarrays in Alzheimer's disease Masumura, Makoto
2000
21 S1 p. 162-
1 p.
artikel
397 Differential temporal patterns in category and letter-based fluency: Implications for diagnosis and localization Fernaeus, Sven-Erik
2000
21 S1 p. 159-
1 p.
artikel
398 Differentiating dementia with lewy bodies from Alzheimer's disease and Parkinson's disease: Potential for the Cambridge neuropsychological test automated batteries Papka, Michelle
2000
21 S1 p. 216-
1 p.
artikel
399 Differentiation of two subgroups of dementia with lewy bodies from Alzheimer's disease Del-Ser, Teodoro
2000
21 S1 p. 147-
1 p.
artikel
400 Different patterns of cerebral atrophy in semantic dementia and Alzheimer's disease: A volumetric MRI study Chan, Dennis
2000
21 S1 p. 144-145
2 p.
artikel
401 Diffuse Lewy body dementia: A case study Weaverdyck, Shelly E.
2000
21 S1 p. 268-
1 p.
artikel
402 Dipeptidyl carboxypeptidase 1 gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with co-existing Alzheimer pathology Mattila, Kari M.
2000
21 S1 p. 105-
1 p.
artikel
403 Direct analysis of γ-secretase activity in SH-SY5Y neuroblastoma cells identifies the Golgi as the main compartment of amyloid-β(X-40) peptide. Generation Beher, Dirk
2000
21 S1 p. 187-
1 p.
artikel
404 Discriminant power of a combination of IMP-SPECT and CSF-tau protein in the early diagnosis of Alzheimer's disease Okamura, Nobuyuki
2000
21 S1 p. 144-
1 p.
artikel
405 Disregulation of tuberin and P21RAS-GAP in Alzheimer's disease Smith, Jaime J.
2000
21 S1 p. 185-
1 p.
artikel
406 Disruption of pre-deposited Alzheimer's aβ 1–42 fibrils by PTI-00703 (cat's claw derivative) in a rodent model of Aβ fibrillogenesis Cummings, Joel A.
2000
21 S1 p. 153-
1 p.
artikel
407 Distinct human pathogenic mutants of the prion protein display distinct cellular phenotypes Windi, Otto
2000
21 S1 p. 257-
1 p.
artikel
408 Distribution of neuronal mitogen-activated protein kinase (MAPK) and its upstream MAPK kinase (MAPKK) in human brains staged for Alzheimer's disease neurofibrillary degeneration Pei, Jin-Jing
2000
21 S1 p. 55-
1 p.
artikel
409 Dityrosine cross-linking promotes formation of stable α-synuclein polymers Giasson, Benoit I.
2000
21 S1 p. 59-
1 p.
artikel
410 Diversification of γ-secretase versus β-secretase inhibition by cholesterol depletion Bergmann, Christine
2000
21 S1 p. 278-
1 p.
artikel
411 DLST allele found as yet only in Alzheimer patients Brown, Abraham M.
2000
21 S1 p. 175-
1 p.
artikel
412 DNA replication is associated with nerve cell loss in Alzheimer's disease Yang, Yan
2000
21 S1 p. 118-119
2 p.
artikel
413 Does apolipoprotein E (APO E) genotype influence nicotinic receptor binding in Alzheimer's disease? Sabbagh, Marwan N.
2000
21 S1 p. 227-
1 p.
artikel
414 Does hypertension affect the risk and age at onset of Alzheimer disease? Guo, Zhenchao
2000
21 S1 p. 244-
1 p.
artikel
415 Do inhibitors of β-amyloid aggregation also inhibit the aggregation of other amyloid-forming peptides? Moore, Susan
2000
21 S1 p. 12-
1 p.
artikel
416 Dominant phenotypes caused by overexpression of human amyloid precursor protein (APP) in flies Konsolaki, Mary
2000
21 S1 p. 151-
1 p.
artikel
417 Donepezil and rivastigmine improve P300 latency and neuropsychological test scores in Alzheimer's disease patients: One year follow up compared with vit E treated patients Thomas, Astrid
2000
21 S1 p. 167-
1 p.
artikel
418 Donepezil Italian global impact study (DIGIS) Tettamanti, Mauro
2000
21 S1 p. 239-
1 p.
artikel
419 Donepezil provides benefits in global function in moderate to severe Alzheimer's disease Feldman, Howard
2000
21 S1 p. 93-
1 p.
artikel
420 Donepezil provides long-term clinical benefits for patients with Alzheimer's disease Pratt, Raymond D.
2000
21 S1 p. 95-
1 p.
artikel
421 Donepezil treatment in patients with moderate to severe Alzheimer's disease reduces caregiver stress Vellas, Bruno
2000
21 S1 p. 94-
1 p.
artikel
422 Dose-dependent effects of anapsos in senile dementia patients: A double-blind, randomized, placebo controlled study Alvarez, Anton
2000
21 S1 p. 218-
1 p.
artikel
423 Do vascular alterations play a role in Alzheimers disease? Marcos, Alberto
2000
21 S1 p. 29-
1 p.
artikel
424 Dramatic reversibility of inclusion body neuropathology in ApoE deficient mice FED antioxidants Veurink, Gerald
2000
21 S1 p. 227-
1 p.
artikel
425 Drastic loss of rat hippocampal CA1 neurons by D-Ser26 β-amyloid with excitatory amino acids Kaneko, Isao
2000
21 S1 p. 224-
1 p.
artikel
426 Duration of non-steroidal anti-inflammatory drug use and risk of Alzheimer's disease. The Rotterdam study In 't Veld, Bas A.
2000
21 S1 p. 204-
1 p.
artikel
427 Dynamics of presenilin1-mediated notch1 signaling and proteolysis Martys Zage, Jayme L.
2000
21 S1 p. 190-
1 p.
artikel
428 Dystriphic neurites in plaque-like Aβdeposits in mice double transgenic for the APP 670 671 mutation and the human four-repeat tau protein Tolnay, Markus
2000
21 S1 p. 192-
1 p.
artikel
429 Early β-amyloid deposition in hippocampal neurons in β-amyloid precursor protein 695 (APP695) transgenic mice Shie, Feng-Shiun
2000
21 S1 p. 225-
1 p.
artikel
430 Early appearance of degenerative changes in the olfactory system in Alzheimer's disease Christen-Zaech, Stephanie
2000
21 S1 p. 193-
1 p.
artikel
431 Early detection of Alzheimer's disease using neuropsychological testing Albert, Marilyn S.
2000
21 S1 p. 73-
1 p.
artikel
432 Early detection of cognitive decline in high functioning older adults Cholerton, Brenna A.
2000
21 S1 p. 164-
1 p.
artikel
433 Early differential alterations of cholinergic and non-cholinergic cortical presynaptic boutons in transgenic mice displaying amyloid deposition Hu, Linsen
2000
21 S1 p. 89-
1 p.
artikel
434 Early events in the folding of APP Goldgaber, Dmitry
2000
21 S1 p. 198-
1 p.
artikel
435 Early intervention with a cholinesterase inhibitor produces long-term beneficial effects in moderately severe AD patients Doraiswamy, Murali
2000
21 S1 p. 275-
1 p.
artikel
436 Early-onset amyloid deposition in TGCRND8 mice expressing a mutant amyloid precursor protein transgene (APP695KM670/671NL + V717F) Chrishti, M.Azhar
2000
21 S1 p. 126-
1 p.
artikel
437 Early-onset familial Alzheimer's disease and spastic paraparesis associated with a novel insectional mutation of the presenilin 1 gene Moretti, Paolo M.
2000
21 S1 p. 175-
1 p.
artikel
438 Early prediction and longitudinal monitoring of questionably demented, mild Alzheimer's disease and depressed patients as compared to elderly controls: Preliminary results Swainson, Rachel
2000
21 S1 p. 81-
1 p.
artikel
439 Ectopic expression of the mitotic CDC2/Cyclin B kinase in postmitotic neurons triggers degeneration Vincent, Inez
2000
21 S1 p. 182-
1 p.
artikel
440 Education, ApoE status and cognitive impairment in elderly. An epidemiological study in a rural setting Codemo, Alessandra
2000
21 S1 p. 246-
1 p.
artikel
441 Effectiveness of donepezil on behavioral disturbances in mild to moderate Alzheimer's disease patients McRae, Thomas
2000
21 S1 p. 93-
1 p.
artikel
442 Effect of a comprehensive exercise program on function in nursing home residents with Alzheimer's disease Tappen, Ruth M.
2000
21 S1 p. 235-
1 p.
artikel
443 Effect of apolipoproteinβ4 and tau gene polymorphisms on age of onset in Swedish Alzheimer's disease sib-pairs Lilius, Lena
2000
21 S1 p. 63-
1 p.
artikel
444 Effect of (-)clausenamide on impairment of memory and apoptosis Zhang, Jun-Tian
2000
21 S1 p. 243-
1 p.
artikel
445 Effect of donepezil on behavior and activities of daily living in clinical practice Frolich, Lutz
2000
21 S1 p. 161-
1 p.
artikel
446 Effect of donepezil treatment on visual attention/exploration tasks in patients with Alzheimer's disease: Results of a pilot study Geldmacher, David S.
2000
21 S1 p. 169-
1 p.
artikel
447 Effect of estrogen on cerebral glucose metabolism in postmenopausal women Eberling, Jamie L.
2000
21 S1 p. 40-
1 p.
artikel
448 Effect of familial Alzheimer's disease mutations on the formation of presenilin aggregates in proteasome inhibitor treated cells Kovacs, Dora M.
2000
21 S1 p. 198-
1 p.
artikel
449 Effect of mitochondrial inhibitors on [3H]choline incorporation into choline metabolites in cholinergic LA-N-2 cells Utal, Amandip K.
2000
21 S1 p. 183-
1 p.
artikel
450 Effects of Alzheimer-related presenilin-1 mutations on oxidative stress and cell death in transgenic mice Eckert, Anne
2000
21 S1 p. 43-
1 p.
artikel
451 Effects of amyloid β protein on the expressed receptors in xenopus oocytes with MRNA from aged rat brain tissues Funan, Huang
2000
21 S1 p. 9-
1 p.
artikel
452 Effects of apoptosis on the secretion and processing of beta-secretase cleaved amyloid precursor protein in primary rat cortical cultures Sennvik, Kristina
2000
21 S1 p. 217-
1 p.
artikel
453 Effects of a rater training program on the clinician interview based impression of change (cibic-plus) Ferris, Steven H.
2000
21 S1 p. 27-
1 p.
artikel
454 Effects of cerebrolysin in human APP transgenic animal models of Alzheimer's disease Rockenstein, Edward
2000
21 S1 p. 168-
1 p.
artikel
455 Effects of Chinese medicinal herb combination L962 capsule on four kinds of dementia-mimic animal models Li, Lin
2000
21 S1 p. 167-
1 p.
artikel
456 Effects of chronic CSF drainage on cognition and concentration of biochemical markers in Alzheimer's disease: Report of a phase I clinical trial Silverberg, Gerald D.
2000
21 S1 p. 233-
1 p.
artikel
457 Effects of conjugated estrogens and raloxifene on inflammatory reaction induced by amyloid-β Thomas, Tom T.
2000
21 S1 p. 273-
1 p.
artikel
458 Effects of copper and zinc on amyloid precursor protein function and metabolism Multhaup, Gerd
2000
21 S1 p. 50-
1 p.
artikel
459 Effects of cortisol on cognition and FDG-pet in healthy young and old subjects Wolf, Oliver T.
2000
21 S1 p. 157-
1 p.
artikel
460 Effects of donepezil on cognition and functional ability in patients with Alzheimer's disease: Preliminary findings from the Australian subset of a global clinical experience study Bahra, Ranbir
2000
21 S1 p. 146-
1 p.
artikel
461 Effects of donepezil on patient health-related quality of life and caregiver perception in Alzheimer's disease: Preliminary findings from the Australian subset of a global clinical experience study O'Leary, Majella
2000
21 S1 p. 146-
1 p.
artikel
462 Effects of estrogen on cognitive functions and amyloid metabolism in amyloid precursor protein and presenilin-1 double transgenic mice Puolivali, Jukka
2000
21 S1 p. 225-
1 p.
artikel
463 Effects of FTDP-17 mutations of tau on tau functions Barghorn, Stefan
2000
21 S1 p. 15-
1 p.
artikel
464 Effects of insulin on cerebrospinal fluid levels of Aβ42 Craft, Suzanne
2000
21 S1 p. 272-
1 p.
artikel
465 Effects of intra-Aβ mutations on Aβ secretion from transiently transfected cells Stenh, Charlotte
2000
21 S1 p. 247-
1 p.
artikel
466 Effects of presenilin-1 exon 9 deletion and L250S mutations on hyperosmotic stress-induced apoptosis and caspase activities in SH-SY5Y neuroblastoma cells Cowburn, Richard F.
2000
21 S1 p. 163-
1 p.
artikel
467 Effects of presenilin 2 in the early secretory pathway Tekirian, Tina L.
2000
21 S1 p. 159-
1 p.
artikel
468 Effects of presenilin mutations on γ-secretase cleavage and turnover of the amyloid β-protein precursor C-terminal fragment Pack-Chung, Eunju
2000
21 S1 p. 186-
1 p.
artikel
469 Effects of smoking and alcohol on Alzheimer disease: The mirage study Cupples, Adrienne
2000
21 S1 p. 34-
1 p.
artikel
470 Effects of staurosporine-mediated cell death on aβproduction and caspase-mediated cleavage of amyloid precursor protein and presenilins Tesco, Giuseppina
2000
21 S1 p. 68-
1 p.
artikel
471 Effects on APP processing and Aβ-production by CHAP-21/P519, a second membrane type aspartyl protease related to β-secretase Basi, Guriqbal S.
2000
21 S1 p. 116-
1 p.
artikel
472 Electron microscopy and X-ray diffraction studies further confirm the efficacy of PTI-000703™ (Cat's claw derivative) as a potent inhibitor of Alzheimer's beta-amyloid protein fibrillogenesis Castillo, Gerardo M.
2000
21 S1 p. 58-
1 p.
artikel
473 Elevated amyloid β-peptides in brain: Correlation with cognitive decline Naslund, Jan D.
2000
21 S1 p. 273-
1 p.
artikel
474 Elevated systolic blood pressure and high cholesterol levels at midlife are risk factors for late-life dementia Kivipelto, Miia
2000
21 S1 p. 174-
1 p.
artikel
475 Emotion processing in Alzheimer's disease Radford, Shirley A.
2000
21 S1 p. 13-
1 p.
artikel
476 Endocytic alterations in human preclinical AD and a trisomic mouse model of down syndrome: Implications for β-amyloidogenesis Cataldo, Anne M.
2000
21 S1 p. 65-
1 p.
artikel
477 Endosomal-lysosomal mechanisms in amyloido-genesis and neurodegeneration: Animal models Nixon, Ralph A.
2000
21 S1 p. 72-
1 p.
artikel
478 Energy expenditure and Alzheimer disease Gambina, Giuseppe
2000
21 S1 p. 14-15
2 p.
artikel
479 Energy processes of the human brain in normal aging and dementia of Alzheimer's type Fokin, Vitaly Feodor
2000
21 S1 p. 157-
1 p.
artikel
480 Enhanced neuronal and astroglial expression of the anti-oxidant enzyme NAD(P)H:Quinone oxido-reductase (NQ01) in the Alzheimer's disease brain Van Muiswinkel, Freek L.
2000
21 S1 p. 55-
1 p.
artikel
481 Enhanced redox interaction of copper-Aβ by homocysteine Huang, Xudong
2000
21 S1 p. 62-
1 p.
artikel
482 Entorhinal cortex and hippocampus in Alzheimer's disease, subcortical ischemic vascular dementia and mixed dementia Du, Antao
2000
21 S1 p. 198-
1 p.
artikel
483 Entorhinal cortex atrophy and apoe Soininen, Hikka
2000
21 S1 p. 2-3
2 p.
artikel
484 Epidemiologic studies of nonsteroidal anti-inflammatory drugs and Alzheimer's disease Kawas, Claudia
2000
21 S1 p. 286-
1 p.
artikel
485 Epidemiology of aging and dementia in down syndrome Schupf, Nicole
2000
21 S1 p. 138-
1 p.
artikel
486 Epidemiology of Alzheimer's disease Katzman, Robert
2000
21 S1 p. 1-
1 p.
artikel
487 Erab and Lewy body pathology Kida, Elzbieta
2000
21 S1 p. 121-
1 p.
artikel
488 ERBB-4 activation promotes neurite outgrowth and cell survival in PC12 cells Pinkas-Kramarski, Ronit
2000
21 S1 p. 118-
1 p.
artikel
489 Erythrocyte antioxidant enzyme activities in Alzheimer's patients and other dementia Leszek, Jerzy
2000
21 S1 p. 154-155
2 p.
artikel
490 Establishment of Alzheimer's multi-symptom copied model Lao, Huanmin
2000
21 S1 p. 152-
1 p.
artikel
491 Establishment of the transgenic model of Alzheimers disease Chuan, Qin
2000
21 S1 p. 20-
1 p.
artikel
492 17-β-Estradiol induction of caspase inhibitory factor in human neurons Zhang, Yan
2000
21 S1 p. 160-
1 p.
artikel
493 Estrogen: Associations for dementia risks and neuropsychiatric symptoms Senanarong, Vorapun
2000
21 S1 p. 216-
1 p.
artikel
494 Estrogen enhances phagocytosis of amyloid β protein by microglia derived from human cortex Li, Rena
2000
21 S1 p. 182-
1 p.
artikel
495 Estrogen in Alzheimer's disease: Treatment or prevention Sano, Mary
2000
21 S1 p. 212-
1 p.
artikel
496 Estrogen receptor β gene polymorphisms in Alzheimer type dementia patients in a Japanese population Wakutani, Yosuke
2000
21 S1 p. 104-
1 p.
artikel
497 Estrogen replacement therapy and mild cognitive impairment (MCI): A population-based study Hallikainen, Merja
2000
21 S1 p. 232-233
2 p.
artikel
498 Estrogen replacement therapy for women with Alzheimer's disease Kandel, Ruth
2000
21 S1 p. 241-
1 p.
artikel
499 Estrogen's modulation of brain function in monkeys Voytko, Mary Lou
2000
21 S1 p. 71-
1 p.
artikel
500 Estrogen status controls brain abeta levels in guinea pigs and in plaque-forming transgenic mice Gandy, Sam
2000
21 S1 p. 213-
1 p.
artikel
501 Ethical considerations: The feasibility of recruiting and interviewing adults with dementia for non-therapeutic research via medical professionals Mason, Anne C.
2000
21 S1 p. 174-
1 p.
artikel
502 Ethical guidelines in brain banking of neurodegenerative and psychiatric disorders Ravid, Rivka
2000
21 S1 p. 248-
1 p.
artikel
503 Ethical principles for ageing and Alzheimer's disease in mount athos Baloyannis, Stavros j.
2000
21 S1 p. 174-
1 p.
artikel
504 Ethnicity-dependent association of the cathepsin D C224T polymorphism with Alzheimer's disease Freeman, Melissa J.
2000
21 S1 p. 104-
1 p.
artikel
505 Ethnic variability in genotypic risks of Alzheimer's disease Mayeux, Richard
2000
21 S1 p. 137-
1 p.
artikel
506 Evaluation of cerebral decline in Alzheimer's dementia: Implications for using resting positron emission tomography and magnetic resonance imaging morphometry as outcome measures in long-term treatment studies Alexander, Gene E.
2000
21 S1 p. 40-
1 p.
artikel
507 Evaluation of the effects of therapy in individual patients with Alzheimer's disease; limitations and opportunities Richard, Edo
2000
21 S1 p. 239-
1 p.
artikel
508 Event related evoked potential P300 in frontotemporal dementia Jimenez-Escrig, Adriano
2000
21 S1 p. 97-
1 p.
artikel
509 Event-related potentials and reaction time can distinguish healthy aging from mild Alzheimer's disease Golob, Edward J.
2000
21 S1 p. 229-
1 p.
artikel
510 Evidence for a neuroprotective role for corticotropin-releasing hormone against amyloid toxicity in experimental models of Alzheimer's disease Pedersen, W.A.
2000
21 S1 p. 86-
1 p.
artikel
511 Evidence for a possible association of Aβ-generation with the intracellular trafficking of lipoprotein-derived cholesterol Runz, Heiko
2000
21 S1 p. 189-
1 p.
artikel
512 Expression of adaptor protein AP-2 in Alzheimer's disease Yao, Pamela J.
2000
21 S1 p. 182-
1 p.
artikel
513 Expression of amyloid precursor protein and presenilin-1 in transgenic mice Czech, Christian
2000
21 S1 p. 20-
1 p.
artikel
514 Expression of nicotinic achetylcholine receptor subunits in ache-transgenic mice Svedberg, Marie M.
2000
21 S1 p. 153-
1 p.
artikel
515 Expression of presenilin-2 enhances apoptotic death of primary cortical neurons Araki, Wataru
2000
21 S1 p. 262-
1 p.
artikel
516 Expression of two novel β-secretase-candidate aspartyl proteases in Alzheimer's disease and down syndrome brain Howlett, David R.
2000
21 S1 p. 119-
1 p.
artikel
517 Extrapyramidal signs and the rate of clinical progression in Alzheimer's disease Pfeffer, Anna
2000
21 S1 p. 15-
1 p.
artikel
518 334extrapyramidal symptoms and signs in Alzheimer's: Prevalence and correlation with neurological findings Tsolaki, Magda
2000
21 S1 p. 94-
1 p.
artikel
519 Ex vivo propagation of transmissible spongiform encephalopathies agents Lehmann, Sylvain
2000
21 S1 p. 58-
1 p.
artikel
520 Facilitation of β-catenin signaling by presenilin-1 Koo, Edward H.
2000
21 S1 p. 4-
1 p.
artikel
521 Factorial and discriminant analyses of neuropsychological variables in familial and sporadic late onset Alzheimer disease Lopera, Francisco
2000
21 S1 p. 230-
1 p.
artikel
522 Fad alleles of PS1 and PS2 have divergent effects on skeletal development, γ-40 and γ-42-secretase Westaway, David A.
2000
21 S1 p. 133-
1 p.
artikel
523 Familial Alzheimer's disease-linked presenilin1 mutants provoke transcriptional down-regulation of ER molecular chaperones Katayama, Taiichi
2000
21 S1 p. 257-
1 p.
artikel
524 Familial and sporadic Alzheimer's disease progress at the same rate Janssen, John C.
2000
21 S1 p. 178-
1 p.
artikel
525 Familial frontotemporal dementia with a novel tau exon-10 splice site mutation: Nature confirms a theoretic construct Dickson, Dennis W.
2000
21 S1 p. 65-
1 p.
artikel
526 Familial presenile dementia with Parkinsonism in a Japanese family Takao, Masaki
2000
21 S1 p. 267-
1 p.
artikel
527 Family caregivers' Willingness To Pay (WTP) Werner, Perla
2000
21 S1 p. 217-
1 p.
artikel
528 FE65 in Alzheimer disease: Neuronal distribution and colocalization with TAU Delatour, Benoit
2000
21 S1 p. 193-
1 p.
artikel
529 Female gonadal hormone status controls the metabolism of brain amyloid β peptides Petanceska, Suzana S.
2000
21 S1 p. 270-
1 p.
artikel
530 FE65 regulates the processing of the amyloid precursor protein (APP) Mercken, Luc
2000
21 S1 p. 219-
1 p.
artikel
531 Fibulin-1 binds the amino-terminal head of β-amyloid precursor protein and modulates its phyiological function Ohsawa, Ikuroh
2000
21 S1 p. 112-
1 p.
artikel
532 Fine-mapping of the chromosome 12 Alzheimer disease locus using family-based association tests of microsatellite markers Scott, William K.
2000
21 S1 p. 129-
1 p.
artikel
533 Frameshift mutations in neuronal MRNAS: implications for sporadic Alzheimer's disease Hol, Elly M.
2000
21 S1 p. 109-
1 p.
artikel
534 Frontal hypometabolism in mild Alzheimer's disease is associated with more rapid progression of dementia Foster, Norman L.
2000
21 S1 p. 108-
1 p.
artikel
535 FTDP-17 mutations of tau have multiple effects on its biochemical and physiochemical properties Nacharaju, Parimala
2000
21 S1 p. 196-
1 p.
artikel
536 Functional analysis of beta-secretase using mutagenesis and structural homology modeling McConlogue, Lisa Claire
2000
21 S1 p. 278-
1 p.
artikel
537 Functional analysis of the macromolecular complexes involving the APP binding adaptor FE65 Russo, Tommaso
2000
21 S1 p. 263-
1 p.
artikel
538 Functional and morphometric MRI evidence of specific structure/function relationships underlying memory dysfunction in early Alzheimer's disease Saykin, Andrew J.
2000
21 S1 p. 201-
1 p.
artikel
539 Functional assessment tools and their use in long term management of Alzheimer's disease Gauthier, Serge
2000
21 S1 p. 75-
1 p.
artikel
540 Functional brain imaging in subjects at genetic risk for Alzheimer's disease Reiman, Eric M.
2000
21 S1 p. 141-
1 p.
artikel
541 Functional - cognitive assessment scale a new scale to predict early dementia and follow up Tsolaki, Magda Ch.
2000
21 S1 p. 235-
1 p.
artikel
542 Functional disconnectivity and instability of the distribution of electrically active neurons in vascular dementia Tsuno, Norifumi
2000
21 S1 p. 149-
1 p.
artikel
543 Functional imaging in the early detection of cognitive impairment Stern, Yaakov
2000
21 S1 p. 3-
1 p.
artikel
544 Functional MRI studies of hippocampal activation in aging and AD Sperling, Reisa A.
2000
21 S1 p. 2-
1 p.
artikel
545 Functional neuroimaging of sentence comprehension in frontotemporal dementia Cooke, Ayanna N.
2000
21 S1 p. 143-
1 p.
artikel
546 Functional role of transcription factors during aβinduced neuronal cell death Bowser, Robert P.
2000
21 S1 p. 53-
1 p.
artikel
547 Functional segregation of medial temporal lobe activation during encoding and recognition of visuospatial scenes Rombouts, Serge A.R.B.
2000
21 S1 p. 107-
1 p.
artikel
548 Function of proteins interacting with the cytoplasmic domain of APP Suzuki, Toshiharu
2000
21 S1 p. 187-
1 p.
artikel
549 Galantamine alleviates caregiver burden in Alzheimer's disease: A 6-month placebo-controlled study Wilcock, Gordon K.
2000
21 S1 p. 241-
1 p.
artikel
550 Galantamine: An allosterically potentiating ligand of nicotinic acetylcholine receptors Albuquerque, Edson X.
2000
21 S1 p. 168-169
2 p.
artikel
551 Galantamine postpones the emergence of behavioral symptoms in alzheimer's disease: A 5-month, randomized, placebo-controlled study Tariot, Pierre N.
2000
21 S1 p. 240-
1 p.
artikel
552 Galantamine produces long-term cognitive and functional benefits in patients with Alzheimer's disease Jacobo, Mintzer E.
2000
21 S1 p. 168-
1 p.
artikel
553 Galantamine's clinical benefits are not offset by sleep disturbance: A 3-month placebo-controlled study in patients with Alzheimer's disease Rockwood, Kenneth
2000
21 S1 p. 239-
1 p.
artikel
554 Gender differences in morbidity, dementia and disability, findings from a population-based study of the oldest old in Stockholm von Strauss, Eva Ingmarie
2000
21 S1 p. 100-
1 p.
artikel
555 Gender differences of visuospatial performance Riepe, Matthias W.
2000
21 S1 p. 178-
1 p.
artikel
556 Gender specific association of the angiotensin converting enzyme gene with Alzheimer's disease Abdullah, Laila
2000
21 S1 p. 37-
1 p.
artikel
557 Generation and degradation of amyloid β early in the secretory pathway: Monitoring distinct protease activities in a novel in vitro γ-secretase assay Fechteler, Katja
2000
21 S1 p. 279-
1 p.
artikel
558 Generation of adenovirus vectors for cell models of Alzheimer's disease Vogel, Roland
2000
21 S1 p. 84-85
2 p.
artikel
559 Generation of an animal model of amyloid deposition without overproduction of amyloid precursor protein Flood, Dorothy G.
2000
21 S1 p. 133-
1 p.
artikel
560 Generation of autoantibodies towards Alzheimer's disease vaccination Solomon, Beka
2000
21 S1 p. 271-
1 p.
artikel
561 ‘Generic’ versus condition-specific quality of life measures in middle to late stage dementia Currie, Gillian R.
2000
21 S1 p. 124-
1 p.
artikel
562 Genetic analysis of the FE65 intron 13 biallelic polymorphism in a family-based and a case control study Guenette, Suzanne Y.
2000
21 S1 p. 250-
1 p.
artikel
563 Genetic and clinical follow-up of a twin set discordant for Alzheimer's disease Bertolucci, Paulo Henrique
2000
21 S1 p. 38-
1 p.
artikel
564 Genetic association between alpha 2-macroglobulin gene and Alzheimer's disease in the French population Verpillat, Patrice
2000
21 S1 p. 173-
1 p.
artikel
565 Genetic association between Alzheimer's disease and the low density lipoprotein receptor-related protein gene in the French population Verpillat, Patrice
2000
21 S1 p. 64-
1 p.
artikel
566 Genetic linkage analysis and molecular characterization of candidate β-secretases, BACE1 and BACE2 Saunders, Aleister J.
2000
21 S1 p. 270-
1 p.
artikel
567 Genetic linkage studies of Alzheimer's disease in Israeli arabs Farrer, Lindsay A.
2000
21 S1 p. 128-
1 p.
artikel
568 Genetic risk factors for Alzheimer's disease — α2macroglobulin polymorphism in polish patients Styczynska, Maria
2000
21 S1 p. 176-
1 p.
artikel
569 Genetics and biology of the presenilins and their interacting proteins St George-Hyslop, Peter H.
2000
21 S1 p. 75-
1 p.
artikel
570 Genetics and pathophysiology of Alzheimer's disease Lannfelt, Lars
2000
21 S1 p. 211-
1 p.
artikel
571 Genetic screen for presenilin-interacting genes in drosophila Livne-Bar, Izhar
2000
21 S1 p. 204-205
2 p.
artikel
572 Genetics of Alzheimer disease in the Caribbean Hispanic population Catania, Jennifer W.
2000
21 S1 p. 37-
1 p.
artikel
573 Genetics of tau dementia Heutink, Peter
2000
21 S1 p. 284-
1 p.
artikel
574 Genome-wide linkage disequilibrium mapping of late onset Alzheimer's disease in Finland Hiltunen, Mikko J.
2000
21 S1 p. 12-
1 p.
artikel
575 Genomic screen of 739 sibpairs with late onset Alzheimer disease Haines, Jonathan L.
2000
21 S1 p. 129-
1 p.
artikel
576 Global intellectual deterioration in patients with alzheimer's disease — the reverse of the model of intellectual development: A proposal of a “G relationship” using the binet scale and pet Shimada, Masumi
2000
21 S1 p. 221-
1 p.
artikel
577 Glutamate uptake is decreased in platelets from Alzheimer and down patients Ferrarese, Carlo
2000
21 S1 p. 156-
1 p.
artikel
578 Glutamine synthetase is reduced in astrocytes and abnormally expressed by pyramidal neurons in Alzheimer's disease Robinson, Stephen R.
2000
21 S1 p. 46-
1 p.
artikel
579 Glycosylation of tau protein occurs earlier than its hyperphosphorylation in Alzheimer's disease Liu, Fei
2000
21 S1 p. 16-
1 p.
artikel
580 Granzyme B and M, inflammation- and cytotoxicity-associated serine proteinases, are present in plaques, tangles and dystrophic neurites in AD brain McGraw, Walker T.
2000
21 S1 p. 270-
1 p.
artikel
581 Health outcomes and effectiveness of atypical antipsychotics in outpatients with psychosis or agitation associated with AD Schneider, Lon S.
2000
21 S1 p. 166-
1 p.
artikel
582 Healthy brain aging in nonagenarian and centenarians Morris, John C.
2000
21 S1 p. 280-281
2 p.
artikel
583 Hemispheric and functional specialization of the frontal lobes: Volumetric measurements and neuropsychological features in frontotemporal dementia Lindau, Maria
2000
21 S1 p. 201-
1 p.
artikel
584 Herbal formulation in the treatment of age-related cognitive decline in elderly subjects: A double blind study from India Vaswani, Meera
2000
21 S1 p. 166-
1 p.
artikel
585 Hereditary lateral sclerosis and Alzheimer disease associated with mutation at codon 261 of the presenilin 1 (PS1) gene Farlow, Martin R.
2000
21 S1 p. 62-
1 p.
artikel
586 Heterogeneity in cerebral metabolism in patients with mild cognitive impairment: A pet study Lautenschlager, Nicola T.
2000
21 S1 p. 127-
1 p.
artikel
587 Heterogeneity of regional cerebral glucose metabolic patterns in neuropathologically confirmed Alzheimer's disease patients Pietrini, Pietro
2000
21 S1 p. 251-
1 p.
artikel
588 High A42 causing presenilin 1 mutations lead to the cotton wool plaques/spastic paraparesis variant of Alzheimer's disease Hardy, John A.
2000
21 S1 p. 212-
1 p.
artikel
589 High APOE-ϵ allele frequencies in elderly kikuyu in Kenya Patel, Nilesh B.
2000
21 S1 p. 64-
1 p.
artikel
590 High cholesterol level and depressive symptoms in dementia Lebert, Florence
2000
21 S1 p. 236-
1 p.
artikel
591 Hippocampal and entorhinal atrophy in aging Alzheimer's disease: Relation to function Toledo-Morrell, Leyla de
2000
21 S1 p. 2-
1 p.
artikel
592 Hippocampal atrophy in mild cognitive impairment. A population-based study Wolf, Henrike
2000
21 S1 p. 252-
1 p.
artikel
593 Hippocampo-entorhinal complex: Selective vulnerability and neuroplasticity burden Mesulam, Marsel
2000
21 S1 p. 2-
1 p.
artikel
594 Histochemical detection of cholesterol in the senile plaques of transgenic APPSW mice Mori, Takashi
2000
21 S1 p. 119-
1 p.
artikel
595 Homicide-suicide and homicide involving patients with Alzheimer's disease and related dementias Cohen, Donna
2000
21 S1 p. 269-
1 p.
artikel
596 Homocystein and cognitive function in the Sacramento area Latino study on aging (Salsa) Miller, Joshua W.
2000
21 S1 p. 204-
1 p.
artikel
597 Homocysteine elicits a DNA damage response in neurons: Mechanism of increased risk for Alzheimer's disease? Kruman, I.I.
2000
21 S1 p. 42-
1 p.
artikel
598 How long is a fly? A test for cognitive estimation in patients with probable Alzheimer's disease Brand, Matthias
2000
21 S1 p. 233-
1 p.
artikel
599 Human amyloid-derived aßcontains tyrosine cross-linked oligomers Atwood, Craig S.
2000
21 S1 p. 199-
1 p.
artikel
600 Human apolipoprotein E4 has a gain-of-negative-function in supporting mossy fiber axon sprouting in organotypic hippocampal slice culture Teter, Bruce
2000
21 S1 p. 186-
1 p.
artikel
601 Human prion diseases Gambetti, Pierluigi
2000
21 S1 p. 280-
1 p.
artikel
602 Human αsynuclein exists in both monomeric and polymeric membrane-bound forms in transgenic mice and MES23.5 dopaminergic cells overexpressing WT and A53T mutant αsynuclein Sharon, Ronit
2000
21 S1 p. 11-
1 p.
artikel
603 Hydroxymethylglutaryl coenzyme a reductase inhibition leads to a caspase-mediated decrease in Aβ secretion by Chinese hamster ovary cells Haske, Taraneh
2000
21 S1 p. 110-
1 p.
artikel
604 Hypercholesterolemia accelerates amyloid pathology in a transgenic mouse model of Alzheimer's amyloidosis Refolo, Lorenzo M.
2000
21 S1 p. 125-
1 p.
artikel
605 Hyperhomocysteinemia in dementia Leblhuber, Friedrich
2000
21 S1 p. 190-
1 p.
artikel
606 Hyperphosphorylation and accumulation of neurofilament protein subunits in Alzheimer disease brain Wang, Jian-Zhi
2000
21 S1 p. 273-
1 p.
artikel
607 Ibuprofen reduces inflammation and plaque pathology in a mouse model for Alzheimer's disease Lim, Giselle P.
2000
21 S1 p. 17-
1 p.
artikel
608 Identification of an apoptotic factor(AF) found in Alzheimer's disease (AD) plasma and isolated from their urine Maesaka, John K.
2000
21 S1 p. 228-229
2 p.
artikel
609 Identification of CD36 and IAP as beta-amyloid mediating receptors on THP1 monocytes Bamberger, Maria E.
2000
21 S1 p. 258-
1 p.
artikel
610 Identification of chlamydia pneumoniae in the Alzheimer's brain Mahony, James B.
2000
21 S1 p. 245-
1 p.
artikel
611 Identification of kinases associated with phosphorylated tau deposits in the brains of transgenic mice bearing mutated amyloid precursor protein and presenilin-1 transgenes Howlett, David R.
2000
21 S1 p. 224-225
2 p.
artikel
612 Identification of novel Alzheimer genes using population-based association studies Ilyas Kamboh, M.
2000
21 S1 p. 212-
1 p.
artikel
613 Identification of ubiquilin, a novel presenilin interactor that modulates presenilin protein accumulation and enhances presenilin induced cell death Monteiro, Mervyn J.
2000
21 S1 p. 259-
1 p.
artikel
614 Ideomotor apraxia in patients with alzheimer's disease: Why do they use their body parts as objects? Kato, Masami
2000
21 S1 p. 218-
1 p.
artikel
615 Idiopathic selective amnesia with slow onset: A descriptive spect study Hoegh, Peter
2000
21 S1 p. 107-
1 p.
artikel
616 IL-1β 1S elevated in brain microvessels in Alzheimer's disease Grammas, Paula
2000
21 S1 p. 79-
1 p.
artikel
617 Immune competent macrophages produce neurotrophic factors Shibata, Annemarie
2000
21 S1 p. 261-
1 p.
artikel
618 Immune reactive cells in senile plaques and cognitive decline in AD Vehmas, Anne K.
2000
21 S1 p. 122-
1 p.
artikel
619 Impact of an educational program on wellbeing of caregivers of patients with dementia Pezzini, Alessandra Ap.
2000
21 S1 p. 196-
1 p.
artikel
620 Impact of coexistent Alzheimer pathology on the natural history of dementia with Lewy bodies Jellinger, Kart A.
2000
21 S1 p. 123-
1 p.
artikel
621 Impact of current therapy on Alzheimer's disease progression Giacobini, Ezio
2000
21 S1 p. 9-
1 p.
artikel
622 Impact of FE651, an APP- and LRP-binding protein, on the endocytic function of LRP Guenette, Suzanne Y.
2000
21 S1 p. 207-
1 p.
artikel
623 Impact of PS mutations and PS null state in adult transgenic mouse brain Van Leuven, Fred
2000
21 S1 p. 140-
1 p.
artikel
624 Impact of the APOE promoter polymorphisms on aβ loading in AD brains Lambert, Jean-Charles
2000
21 S1 p. 205-
1 p.
artikel
625 Impaired hemispatial visual attention ability correlated with decreased contralateral parietal blood flow in patients with alzheimer's disease Somaya, Kyoko
2000
21 S1 p. 220-
1 p.
artikel
626 Impaired microvascular perfusion in Alzheimer's disease: Role of constitutive nitric oxide de la Torre, Jack C.
2000
21 S1 p. 3-
1 p.
artikel
627 Impaired spatial learning and memory in APPCRND8/PS2 double transgenic mice 2000
21 S1 p. 125-
1 p.
artikel
628 Impairment of responses to ER stress in mutant PS1 ‘knock-in’ mouse Kudo, Takashi
2000
21 S1 p. 67-
1 p.
artikel
629 Impairments in attention and fluctuating attention distinguish between dementia with lewy bodies and Alzheimer's disease Ballard, Clive G.
2000
21 S1 p. 147-
1 p.
artikel
630 Impairments of social cognition and decision making in Alzheimer disease Kremer, Janus L.
2000
21 S1 p. 28-
1 p.
artikel
631 Implications of cell surface expression of the Alzheimer's beta-amyloid precursor protein Jung, Sonia S.
2000
21 S1 p. 82-83
2 p.
artikel
632 Improved diagnostic discrimination of patients with Alzheimer's disease and vascular dementia using tau and β-amyloid(1–42) levels in CSF Mielke, Ruediger
2000
21 S1 p. 227-
1 p.
artikel
633 Improvement of cognitive deficits in female APOE4 transgenic mice after treatment with sex steroids Raber, Jacob
2000
21 S1 p. 60-
1 p.
artikel
634 Inactive treatment arms in Alzheimer's disease clinical trials Knopman, David S.
2000
21 S1 p. 5-
1 p.
artikel
635 Incidence rates of Alzheimer's disease among elderly blacks, caribbean-hispanics and whites in Northern Manhattan Tang, Ming-Xin
2000
21 S1 p. 171-
1 p.
artikel
636 Increased β-amyloid deposition in female transgenic mice overexpressing human βAPP Callahan, Michael J.
2000
21 S1 p. 226-227
2 p.
artikel
637 Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice Kim, Yong-Sun
2000
21 S1 p. 86-
1 p.
artikel
638 Increased isoprostane biosynthesis in alzheimer's disease: Correlation of a specific non invasive index of lipid peroxidation with disease severity Pratico, Domenico
2000
21 S1 p. 220-
1 p.
artikel
639 Increased oxidative stress involving olfactory neurons in Alzheimer disease Perry, George
2000
21 S1 p. 89-
1 p.
artikel
640 Increased plasma levels of the soluble lipoprotein receptor-related protein in elderly community dwelling subjects Milward, Elizabeth A.
2000
21 S1 p. 207-
1 p.
artikel
641 Increased presence of amino-terminally-truncated Aβ-peptides in presenilin 1 early-onset familial Alzheimer disease Russo, Claudio
2000
21 S1 p. 194-
1 p.
artikel
642 Increased rates of atrophy in early and preclinical AD: Studies with registration of serial MRI Fox, Nicholas C.
2000
21 S1 p. 74-
1 p.
artikel
643 Increased risk for Alzheimer's disease among women whose spouses engaged in lead-related activities Cook, Thomas B.
2000
21 S1 p. 246-
1 p.
artikel
644 Increased secretion of the β-amyloid precursor protein in PC12 cells treated with a memory-enhancing drug AIT-082 Lahiri, Debomoy K.
2000
21 S1 p. 274-
1 p.
artikel
645 Increased surface expression and processing of amyloid precursor protein in the presence of presenilin 1 mutations Heyn, Sietske N.
2000
21 S1 p. 41-
1 p.
artikel
646 Increased synaptic density in the hippocampus of 24 months old rats after 20 days of treatment with an peptidergic preparation — An explanation for improved spatial memory? Windisch, Manfred
2000
21 S1 p. 85-
1 p.
artikel
647 Increasing the relevance of discourse through one-on-one conversation in Alzheimer's disease Tappen, Ruth M.
2000
21 S1 p. 94-
1 p.
artikel
648 Indiana Alzheimer disease center national cell repository Conneally, P.Michael
2000
21 S1 p. 98-
1 p.
artikel
649 Individualising symptomatic therapy: N-of-1 trials Qizilbash, Nawab
2000
21 S1 p. 165-
1 p.
artikel
650 Individualized interventions for dementia family caregivers: Results of a national policy study Emerson Lombardo, Nancy B.
2000
21 S1 p. 268-
1 p.
artikel
651 In Down syndrome β-amyloid contributes more to neuronal loss than does neurofibrillary degeneration Tarnawski, Michal
2000
21 S1 p. 56-
1 p.
artikel
652 Induction of apoptosis in neuronal cells by a plasma factor found in Alzheimer's disease (AD) O'Rear, Julian J.
2000
21 S1 p. 252-
1 p.
artikel
653 Inflammatory processes in the APP23 mouse model of Alzheimer's disease Staufenbiel, Matthias
2000
21 S1 p. 227-
1 p.
artikel
654 Inflammatory responses and oxidative stresses in PS/aPP mice Matsuoka, Yasuji
2000
21 S1 p. 18-
1 p.
artikel
655 Influence of ‘age-extrinsic’ factors as a determinant of cognitive aging in 1940 healthy subjects aged 25–85: The Maastricht aging study (MAAS) Jolles, Jellemer
2000
21 S1 p. 269-
1 p.
artikel
656 Influence of a memory training program on attention and memory-performance of patients with dementia Bernhardt, Tanja
2000
21 S1 p. 275-
1 p.
artikel
657 Influence of APOE genotype and pet brain imaging on preclinical prediction of Alzheimer disease Small, Gary W.
2000
21 S1 p. 74-
1 p.
artikel
658 Influence of double (APP and PS1) mutations on sprouting in the hippocampus following entorhinal cortex lesions in mice and the effects of estrogen Kadish, Inga
2000
21 S1 p. 88-
1 p.
artikel
659 Influence of PS and FAD-linked PS variants on the mammalian unfolded protein response Sato, Naoyuki
2000
21 S1 p. 259-
1 p.
artikel
660 Informal caregivers' recording of behaviour in elderly persons with dementia: Results of psychometric analysis Borrie, Michael J.
2000
21 S1 p. 236-
1 p.
artikel
661 Informed consent Whitehouse, Peter J.
2000
21 S1 p. 6-
1 p.
artikel
662 Inherited Alzheimer's disease—Olfactory function: A ten year follow-up Nee, Linda Elizabeth
2000
21 S1 p. 165-
1 p.
artikel
663 Inhibition of abeta production and APP maturation by specific PKA inhibitors Su, Yuan
2000
21 S1 p. 236-
1 p.
artikel
664 Inhibition of capacitative calcium entry pathway potentiates presenilin-associated ‘-secretase activities of the amyloid β-precursor protein and Notch Cheng, Isaac
2000
21 S1 p. 118-
1 p.
artikel
665 Innate immunity, autotoxicity and degenerative neurologies McGeer, Patrick L.
2000
21 S1 p. 285-
1 p.
artikel
666 Insulin and cortisol effects of memory in Alzheimer's disease Watson, G.Stennis
2000
21 S1 p. 92-
1 p.
artikel
667 Insulin degrading enzyme expression is reduced in hippocampus of Alzheimer's disease patients Cook, David G.
2000
21 S1 p. 120-
1 p.
artikel
668 Insulin degrading enzyme (IDE): implications for the degradation and neurotoxicity of the amyloid β-protein Vekrellis, Konstantinos
2000
21 S1 p. 115-
1 p.
artikel
669 Insulin-regulated β-amyloid protein trafficking: Stimulated secretion and reduced intracellular accumulation of Aβ in neuronal cell cultures Gasparini, Laura
2000
21 S1 p. 183-
1 p.
artikel
670 Integrating pharmacologic and non-pharmacologic treatment into behavioral management Robins, Peter
2000
21 S1 p. 75-
1 p.
artikel
671 Intellectual and physical activities are protective against the development of Alzheimer's disease Friedland, Robert P.
2000
21 S1 p. 99-
1 p.
artikel
672 Interaction between amyloid precursor protein 695 and a light chain sequence in high molecular weight kininogen Mujamdar, Arpita
2000
21 S1 p. 117-
1 p.
artikel
673 Interaction of apolipoprotein E ϵ4 dosage and activated microglia in deposition of amyloid-β40 and amyloid-β42 in the elderly Warzok, Rolf W.
2000
21 S1 p. 114-
1 p.
artikel
674 Interaction of NAC with Aβprotein in neuronal cell injury in Alzheimer's disease Tanaka, Seigo
2000
21 S1 p. 111-
1 p.
artikel
675 Interactions between calsenilin and the presenilins Wasco, Wilma
2000
21 S1 p. 5-
1 p.
artikel
676 Interferon-γ (IFN-γ) and homocysteine (HCY) may conditionate the release of interleukin-8 (IL-8) from blood mononuclear cells (BMC) in patients with Alzheimer's disease (AD): Potential defensive mechanism Solerte, Sebastiano B.
2000
21 S1 p. 266-
1 p.
artikel
677 Interleukin-1β modulated gene expression in normal human neural progenitor (NHNP) primary cell lines using high density cDNA arrays Lukiw, Walter J.
2000
21 S1 p. 60-61
2 p.
artikel
678 Intracellular A-beta in neuronal and non-neuronal cells Doms, Robert W.
2000
21 S1 p. 70-
1 p.
artikel
679 Intracellular and secreted Aβ42/40 ratios are differently influenced by APP mutations Grimm, Heike Sabine
2000
21 S1 p. 206-
1 p.
artikel
680 Intraneuronal Aβ42 immunoreactivity is inversely correlated with Alzheimer's disease pathology in down syndrome brain: A temporal study Mori, Chica
2000
21 S1 p. 121-
1 p.
artikel
681 Intraneuronal β-amyloid with aging and alzheimer's disease Gouras, Gunnar K.
2000
21 S1 p. 207-
1 p.
artikel
682 Intrinsic ferroxidase activity in the Alzheimer's amyloid precursor protein Rogers, Jack Timothy
2000
21 S1 p. 261-
1 p.
artikel
683 Investigating linguistic and cultural contructions of late-life dementias in urban black Africans Makoni, Sinfree
2000
21 S1 p. 170-
1 p.
artikel
684 Investigating statistical models for understanding cognitive decline in the elderly Lamar, Melissa
2000
21 S1 p. 31-
1 p.
artikel
685 Investigation of a CA repeat close to the estrogen receptor β gene in patients with Alzheimer's disease Forsell, Charlotte
2000
21 S1 p. 27-
1 p.
artikel
686 Investigation of the involvement of the prion protein in oxidative stress Milhavet, Ollivier
2000
21 S1 p. 58-
1 p.
artikel
687 Investigaton of possible associations of 11 poly-morphisms in 8 candidate genes in southeastern African-American Alzheimer disease patients as compared to age-matched controls Perry, Rodney T.
2000
21 S1 p. 12-13
2 p.
artikel
688 In vitro analysis of FTDP-17 linked tau mutations van Slegtenhorst, Marjon
2000
21 S1 p. 51-
1 p.
artikel
689 In-vitro assembly of Aβ 1-40: Morphological investigations and the effect of inhibitors 2000
21 S1 p. 112-
1 p.
artikel
690 In vitro self assembly of abnormally hyperphosphorylated tau into PHF-like structures del C. Alonso, Alejandra
2000
21 S1 p. 197-
1 p.
artikel
691 In vivo analysis of wild-type and FTDP-17 tau mutant mice Goetz, Juergen M.
2000
21 S1 p. 60-
1 p.
artikel
692 In vivo and in vitro experimental axotomy mimics a subtype of dystrophic neurite associated with beta-amyloid plaque formation in Alzheimer's disease Vickers, James C.
2000
21 S1 p. 89-
1 p.
artikel
693 In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease Skovronsky, Daniel M.
2000
21 S1 p. 178-
1 p.
artikel
694 In vivo disrupting of amyloid deposition after injection of β-sheet breaker peptide into cerebral ventricle Permanne, Bruno M.
2000
21 S1 p. 87-
1 p.
artikel
695 In vivo imaging of amyloid deposits in transgenic models of Alzheimer's disease using multi-photon microscopy Bacskai, Brian J.
2000
21 S1 p. 130-
1 p.
artikel
696 Involvement of β-amyloid precursor protein in the regulation of human neural progenitor cell differentiation Sugaya, Kiminobu
2000
21 S1 p. 109-
1 p.
artikel
697 Involvement of presenilins in cell cycle Jeong, Sung-Jin
2000
21 S1 p. 10-
1 p.
artikel
698 Involvement of Rho-associated kinase neurite formation of primary neuronal culture Matsumoto, Naohiko
2000
21 S1 p. 111-
1 p.
artikel
699 Involvement of serum amyloid P component and C-reactive protein in the pathogenesis of Alzheimer's disease Veerhuis, Robert
2000
21 S1 p. 265-
1 p.
artikel
700 Is Alzheimer's amyloid plaque formation a condition for neuronal dysfunction? Koudinov, Alexei R.
2000
21 S1 p. 155-
1 p.
artikel
701 Ischemia, N-methyl D-aspartic acid (NMDA) or interleukin-1β (IL-1β) rapidly and coordinately trigger the expression of presenilin-1 (PS1) and cyclooxygenase-2 (COX-2) in the gerbil hippocampus and in human neural progenitor cells in primary culture Bazan, Nicolas G.
2000
21 S1 p. 249-
1 p.
artikel
702 Is depression a risk factor for dementia or cognitive decline? Jorm, Anthony Francis
2000
21 S1 p. 215-
1 p.
artikel
703 Is education protective? Insights from Swedish twin studies Gatz, Margaret
2000
21 S1 p. 63-
1 p.
artikel
704 Isoform-specific effects of apolipoprotein E on lipid metabolism and on processing of the amyloid precursor protein Michaelson, Daniel M.
2000
21 S1 p. 278-
1 p.
artikel
705 Isolation and characterization of a cDNA encoding a novel drosophila APPL binding protein Taru, Hidenori
2000
21 S1 p. 256-
1 p.
artikel
706 Isolation and characterization of a novel APP binding protein Iijima, Koichi
2000
21 S1 p. 186-
1 p.
artikel
707 Isolation and characterization of primary cortical neurons from rapid autopsies from Alzheimer's disease patients Konishi, Yoshihiro
2000
21 S1 p. 259-
1 p.
artikel
708 Isolation of CDNA encoding a novel protein that associates with neuron-specific X11L protein Lee, Dong-Seok
2000
21 S1 p. 23-
1 p.
artikel
709 Issues for health care purchasers and physicians relating to the use of anti-cholinesterase treatments for Alzheimer's disease Millson, David S.
2000
21 S1 p. 174-
1 p.
artikel
710 Is the brain dysfunction reversible in the persons at risk for Alzheimer disease? Vasilievna Ponomareva, Natalia
2000
21 S1 p. 249-
1 p.
artikel
711 Is there selection bias in autopsy completion? Results from a community-based study Barnhart, Ross L.
2000
21 S1 p. 143-
1 p.
artikel
712 Is very late onset Alzheimer's disease influenced by genetic factors? Silverman, Jeremy M.
2000
21 S1 p. 172-
1 p.
artikel
713 Korean version of the consortium to establish a registry for Alzheimer's disease assessment packet (CERAD-K): Clinical and neuropsychological assessment batteries Lee, Jung Hie
2000
21 S1 p. 32-
1 p.
artikel
714 KPI containing APP in the pathology of Alzheimer's disease Bielby, Keren E.
2000
21 S1 p. 265-
1 p.
artikel
715 Lack of change in average age and MMSE in newly diagnosed AD patients over the last 10 years Riley McCarten, J.
2000
21 S1 p. 158-
1 p.
artikel
716 Lack of genetic association of either A2M or LRP with sporadic Alzheimer's disease McIlroy, Stephen P.
2000
21 S1 p. 103-
1 p.
artikel
717 Lack of relation between CSF and plasma amyloid β proteins in Alzheimer disease Mehta, Pankaj D.
2000
21 S1 p. 228-
1 p.
artikel
718 Late-onset and selective death of motor neurons in transgenic mice overexpressing peripherin Julien, Jean-Pierre
2000
21 S1 p. 213-
1 p.
artikel
719 Leukoaraiosis and cortical atrophy in Alzheimer's disease: A quantitated study using volumetric magnetic resonance imaging Capizzano, Aristides A.
2000
21 S1 p. 178-
1 p.
artikel
720 Lewy bodies may influence symptomatology in some cases of presenilin-related Alzheimer's disease Lippa, Carol F.
2000
21 S1 p. 38-
1 p.
artikel
721 Lewy body pathology in familial (presenilin-2) Alzheimer's disease Fishel, Mark A.
2000
21 S1 p. 66-
1 p.
artikel
722 Lewy-like pathology in mice transgenic for mutant (A53T) human α-synuclein Sommer, Bernd
2000
21 S1 p. 132-
1 p.
artikel
723 Life satisfaction and depression in long term care staff Austrom, Mary Guerriero
2000
21 S1 p. 96-
1 p.
artikel
724 Ligation of microglial CD40 results in SRC kinase-induced P44/42 mapk-dependent TNFα-production Town, Terrence
2000
21 S1 p. 180-
1 p.
artikel
725 Light therapy for sleep-activity disruption in Alzheimer's disease Dowling, Glenna A.
2000
21 S1 p. 232-
1 p.
artikel
726 Linkage analysis of plasma amyloid β protein in typical late onset Alzheimer disease (load) Taner, Nilufer Ertekin
2000
21 S1 p. 130-
1 p.
artikel
727 Linkage disequilibrium as a tool for mapping Alzheimer's disease genes Perez-Tur, Jordi
2000
21 S1 p. 104-
1 p.
artikel
728 Lipids are strong regulators of Aβ production in vivo and in vitro Hartmann, Tobias
2000
21 S1 p. 256-257
2 p.
artikel
729 Lipids, lipoproteins, and the risk of dementia with stroke Moroney, Joan T.
2000
21 S1 p. 7-
1 p.
artikel
730 Lipoprotein(A) affects cognitive function in the elderly. The Italian longitudinal study on aging Panza, Francesco
2000
21 S1 p. 34-
1 p.
artikel
731 Lipoprotein(A) is a risk factor for Alzheimer's disease independently of apolipoprotein E genotype Solfrizzi, Vincenzo
2000
21 S1 p. 64-65
2 p.
artikel
732 Listening to the individual diagnosed with dementia: Results from an early stage dementia peer support group program Toward, Jeffrey I.
2000
21 S1 p. 195-
1 p.
artikel
733 Localization of complexes of presenilin and the APP C-terminal fragments C83 and C99 to the subcellular sites of Aβgeneration Xia, Weiming
2000
21 S1 p. 186-
1 p.
artikel
734 Localization of presenilin at synaptic sites Georgakopoulos, Tassos
2000
21 S1 p. 182-
1 p.
artikel
735 Longitudinal analysis of the effect of apolipoprotein E4 and educational level on cognitive performance in elderly subjects : The PAQUID study Letenneur, Luc
2000
21 S1 p. 246-
1 p.
artikel
736 Longitudinal brain changes in older adults Resnick, Susan M.
2000
21 S1 p. 40-
1 p.
artikel
737 Longitudinal study of psychological burden in caregivers of mild demented patients Oz Zanetti, Orazio
2000
21 S1 p. 194-
1 p.
artikel
738 Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia Street, Jamie S.
2000
21 S1 p. 242-
1 p.
artikel
739 Long term follow-up of dementia in the community Aguero-Torres, Hedda
2000
21 S1 p. 4-
1 p.
artikel
740 Long term rivastigmine treatment produces persistent inhibition of acetyl- and butyrylcholinesterase activity in CSF of Alzheimer's patients Darreh-Shori, Taher
2000
21 S1 p. 243-
1 p.
artikel
741 Looking for drug targets for the treatment of neurological disease — a focus on lipid and cholesterol pathways Schappert, Keith
2000
21 S1 p. 115-
1 p.
artikel
742 Loss of G-protein activity in entorhinal cortex and hippocampus in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and β-amyloid deposits Garcia-Jimenez, Angela
2000
21 S1 p. 120-
1 p.
artikel
743 Loss of presenilin 1 leads to epidermal hyperplasia and tumorigenesis in adult mice Zheng, Hui
2000
21 S1 p. 133-
1 p.
artikel
744 Lower activity of Krebs cycle enzymes than of electron transport in human brain: Disease implications Blass, John P.
2000
21 S1 p. 81-
1 p.
artikel
745 Low levels of vitamin B12 and folate in relation to incidence of Alzheimer's disease Wahlin, Oke
2000
21 S1 p. 172-
1 p.
artikel
746 Magnetic resonance spectroscopy of AD Gonzalez, Gilberto
2000
21 S1 p. 141-
1 p.
artikel
747 Main occupation and risk of Alzheimer's disease and dementia: Preliminary results from a community-based longitudinal study Qiu, Chengxuan
2000
21 S1 p. 192-
1 p.
artikel
748 Marriage with a dementia afflicted spouse Eloniemi-Sulkava, Ulla R.
2000
21 S1 p. 276-
1 p.
artikel
749 Measurement of Aβ40 and Aβ42 using microdialysis coupled to a sensitive sandwich ELISA Durham, Robert A.
2000
21 S1 p. 89-
1 p.
artikel
750 Measurement of cholinergic receptors in APP-overexpressing transgenic mice Paterson, David Stephen
2000
21 S1 p. 225-
1 p.
artikel
751 Mechanism and pathogenesis of cerebral amyloidosis in APP transgenic mice Jucker, M.
2000
21 S1 p. 71-
1 p.
artikel
752 Mechanism of gelsolin-mediated inhibition of fibrillization of amyloid beta-protein Chauhan, Abha
2000
21 S1 p. 217-
1 p.
artikel
753 Mechanism of neurofibrillary degeneration Iqdal, Khalid
2000
21 S1 p. 142-
1 p.
artikel
754 Mechanisms of cell death in Alzheimer's disease: Role of presenilin and mitochondrial function Ankarcrona, Maria
2000
21 S1 p. 282-
1 p.
artikel
755 Mechanisms of oxidative damage in neurodegenerative synucleinopathies Ischiropoulos, Harry
2000
21 S1 p. 283-
1 p.
artikel
756 Mechanisms of synuclein and NAC fibrilogenesis Masliah, Eliezer
2000
21 S1 p. 284-
1 p.
artikel
757 Medial temporal lobe atrophy in MCI Jack, Clifford R.
2000
21 S1 p. 2-
1 p.
artikel
758 Medication utilization in Alzheimer disease and healthy aging: Results in a research registry Mizrahi, Eli H.
2000
21 S1 p. 26-
1 p.
artikel
759 Melatonin attenuates trimethyltin-induced hippocampal neurodegeneration Han, Seol-Heui
2000
21 S1 p. 226-
1 p.
artikel
760 Melatonin reverses the pro-fibrillogenic activity of apolipoprotein E. Pappolla, Miguel A.
2000
21 S1 p. 188-
1 p.
artikel
761 Memantine in moderately severe to severe Alzheimer's disease (AD): Results of a placebo-controlled 6-month trial Reisberg, Barry
2000
21 S1 p. 275-
1 p.
artikel
762 Memantine provides neuroprotection in animal models at therapeutically relevant doses Danysz, Wojciech
2000
21 S1 p. 242-
1 p.
artikel
763 Memantine restores impaired synaptic plasticity by reducing synaptic noise Parsons, Chris G.
2000
21 S1 p. 242-
1 p.
artikel
764 Membrane instability in Aβ-mediated cell death in ad Yang, Austin J.
2000
21 S1 p. 219-
1 p.
artikel
765 Memory complaint in relation to tested cognitive performance and dementia Lin, Ker-Neng
2000
21 S1 p. 232-
1 p.
artikel
766 Memory deficits in patients with Alzheimer's disease and aneurysms of anterior communicating artery Stefanova, Elka D.
2000
21 S1 p. 156-
1 p.
artikel
767 Mental and behavioral disturbances in dementia: Findings from the cache county study on memory in aging Lyketsos, Constantine G.
2000
21 S1 p. 244-
1 p.
artikel
768 Mental work demands protect against cognitive decline; MAAS prospective cohort study Bosma, Hans
2000
21 S1 p. 32-
1 p.
artikel
769 Mesenchymal stem cell therapy for neurodegenerative disease Carter, Janet E.
2000
21 S1 p. 152-
1 p.
artikel
770 Metabolically active rat brain slices as a model for studying neurofibrillary degeneration of Alzheimer's disease Gong, Cheng-Xin
2000
21 S1 p. 10-
1 p.
artikel
771 Metabolic and pathologic discordance in very early Alzheimer's disease Minoshima, Satoshi
2000
21 S1 p. 141-
1 p.
artikel
772 Methylation of genes related to Alzheimer disease in neuroblastoma cells Scarpa, Sigfrido
2000
21 S1 p. 114-
1 p.
artikel
773 Microdensitofluorometrically determined free cholesterol is higher in tangle-bearing neurons than in tangle-free neurons Distl, R.
2000
21 S1 p. 21-
1 p.
artikel
774 Microglial activation in C57BL/6 and A/J strains of mice leads to different levels of brain inflammation Dudal, Sherri
2000
21 S1 p. 18-19
2 p.
artikel
775 Mid-life smoking and late-life Alzheimer's disease: The Honolulu-Asia aging study Tyas, Suzanne L.
2000
21 S1 p. 203-
1 p.
artikel
776 Mild cognitive impairment and the neuroanatomical changes associated with assessment of progression to dementia Murtha, Susan J.E.
2000
21 S1 p. 29-
1 p.
artikel
777 Mild cognitive impairment: Transition from aging to Alzheimer's disease Peterson, Ronald C.
2000
21 S1 p. 1-
1 p.
artikel
778 Mild memory impairment and medical care: Results from a population-based study Albert, Steven M.
2000
21 S1 p. 102-
1 p.
artikel
779 Minimal effects of preclinical Alzheimer's disease on cross-sectional age-related cognitive deficits: Evidence from the Kungsholmen study Jonsson, Erika
2000
21 S1 p. 150-
1 p.
artikel
780 Mitochondrial abnormalities in Alzheimer disease Perry, George
2000
21 S1 p. 213-
1 p.
artikel
781 Mitochondrial abnormalities mark vulnerable neurons in APP YAC transgenic mice Aliev, Gjumrakch
2000
21 S1 p. 267-
1 p.
artikel
782 Mitochondrial impairment in cerebellum from patients with progressive supranuclear palsy Park, Larry Ch.
2000
21 S1 p. 79-
1 p.
artikel
783 Mitochondrial status of caspase inhibitor-saved neurons: Role of membrane potential in commitment(s) to die Johnson Jr., Eugene M.
2000
21 S1 p. 282-
1 p.
artikel
784 Mitotic index and Alzheimer's disease Jenkins, Edmund C.
2000
21 S1 p. 22-
1 p.
artikel
785 M1 muscarinic agonists protect PC12M1 cells from growth factor deprivation and β-amyloids-induced apoptosis Haring, Rachel
2000
21 S1 p. 187-
1 p.
artikel
786 Modeling polyglutamine pathogenesis in mice: SCA1 Orr, Harry T.
2000
21 S1 p. 214-
1 p.
artikel
787 Modification of cysteine proteases and AMPA receptor subunits by the lipid peroxidation product 4-hyroxynonenal: Impact on neuronal apoptosis and necrosis Chan, S.L.
2000
21 S1 p. 17-
1 p.
artikel
788 Modulation of amyloid precursor protein metabolism by X11α/MINT-1. A deletion analysis of protein-protein interaction domains Mueller, Helena T.
2000
21 S1 p. 256-
1 p.
artikel
789 Modulation of β-amyloid precursor protein trafficking and amyloid β-protein secretion by the adaptor protein FE65 Levy, Efrat
2000
21 S1 p. 189-
1 p.
artikel
790 Modulation of AβPP processing by inhibitors of protein trafficking and cholesterol biosynthesis in mixed cortical cultures from TG+2576 AβPP mice Raby, Charlotte A.
2000
21 S1 p. 43-
1 p.
artikel
791 Modulation of the anti-apoptotic transcription factor NF-κB by an endoplasmic reticulum-generated signal Camandola, S.
2000
21 S1 p. 44-
1 p.
artikel
792 Molecular anatomy of amyloid β-peptides in Alzheimer's disease patient's brain by mass spectrometry Wang, Rong
2000
21 S1 p. 155-
1 p.
artikel
793 Molecular and cellular basis for the anti-amyloidogenic effects of estrogen Greenfield, Jeffrey P.
2000
21 S1 p. 190-
1 p.
artikel
794 Molecular basis of presenilin's role in APP processing Selkoe, Dennis J.
2000
21 S1 p. 70-
1 p.
artikel
795 Molecular biological characterization of nicotinic receptors in brain and adrenal medulla Mousavi, Malahat T.
2000
21 S1 p. 42-
1 p.
artikel
796 Molecular characterization of calsenilin, a novel calcium-binding protein, that interacts with the presenilins Choi, Eun-Kyoung
2000
21 S1 p. 117-
1 p.
artikel
797 Molecular characterization of early Alzheimer's disease Spielman, Lauren A.
2000
21 S1 p. 189-
1 p.
artikel
798 Molecular consequences of presenilin mutations Kim, Tae-Wan
2000
21 S1 p. 140-
1 p.
artikel
799 Molecular genetics of chromosome 17 tauopathies Hutton, Michael
2000
21 S1 p. 285-
1 p.
artikel
800 Molecular mechanism of amyloid beta peptides evoked alteration of DNA-bound poly(ADP-ribose) polymerase activity in adult and aged brain Strosznajder, Joanna Benigna
2000
21 S1 p. 253-
1 p.
artikel
801 Molecular mechanism of mitochondrial short chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) involved in Alzheimer's disease He, Xue-Ying
2000
21 S1 p. 45-
1 p.
artikel
802 Molecular mechanism of the neuronal toxicity induced by amyloid-β-protein(1–40) Park, Sun Y.
2000
21 S1 p. 42-
1 p.
artikel
803 Molecular mechanisms and modulation of glial activation: Ligand modulation of biological responses mediated by gene-regulating protein kinases Van Eldik, Linda J.
2000
21 S1 p. 187-188
2 p.
artikel
804 Molecular mechanisms of amyloid formation Lansbury, Peter T.
2000
21 S1 p. 70-
1 p.
artikel
805 Molecular mechanisms of neuronal cell death in animal models of Parkinson's disease Dawson, Ted M.
2000
21 S1 p. 135-
1 p.
artikel
806 Molecular organization of presenilin 1 in the E-cadherin/catenins cell adhesion system Marambaud, Philippe
2000
21 S1 p. 181-
1 p.
artikel
807 Molecular pathological studies of neurofibrillary tangle-predominant form of dementia Saito, Yuko
2000
21 S1 p. 264-
1 p.
artikel
808 Molecular pathology of prion diseases Aguzzi, Adriano
2000
21 S1 p. 1-
1 p.
artikel
809 Molecular studies of prion propagation Collinge, John
2000
21 S1 p. 209-
1 p.
artikel
810 Molecular targets for the inhibition of Aβ production Murphy, Michael P.
2000
21 S1 p. 180-
1 p.
artikel
811 Monitoring the intracellular fate of apolipoprotein E: Implications for Alzheimer's disease Ljungberg, Cecilia M.
2000
21 S1 p. 51-
1 p.
artikel
812 Montessori-based intergenerational programming for dementia: Effects on engagement and affect Camp, Cameron J.
2000
21 S1 p. 62-
1 p.
artikel
813 12-month decline in cognitive and daily function in patients with mild-to-moderate Alzheimer's disease: Two randomized, placebo-controlled studies Torfs, Koen
2000
21 S1 p. 242-243
2 p.
artikel
814 Mortality and apolipoprotein E among caucasians, hispanics, and African-Americans Lee, Joseph H.
2000
21 S1 p. 173-
1 p.
artikel
815 Mortality with dementia: Results from the paquid population-based study Helmer, Catherine
2000
21 S1 p. 35-
1 p.
artikel
816 Motor neuron disease - SOD1 transgenic models Wong, Philip C.Y.
2000
21 S1 p. 214-
1 p.
artikel
817 MPTP toxicity Langston, James W.
2000
21 S1 p. 135-
1 p.
artikel
818 MRI as a longitudinal measure in MCI and AD Rossor, Martin N.
2000
21 S1 p. 142-
1 p.
artikel
819 MRI measurement of hippocampus and amygdala in Alzheimer's disease, vascular dementia and mild cognitive impairment Luning, Wang
2000
21 S1 p. 251-
1 p.
artikel
820 Mutated tau locates preferentially to the cytoplasm Nagiec, Elzbieta E.
2000
21 S1 p. 116-
1 p.
artikel
821 N-acetyltransferase as a risk factor in neurodegenerative disease Ahmed, Abdel Rh.
2000
21 S1 p. 248-
1 p.
artikel
822 Nasal Aβ immunization reduces amyloid-β protein burden in PDAPP mice Lemere, Cynthia A.
2000
21 S1 p. 126-
1 p.
artikel
823 NEBR1: A novel mononuclear phagocyte transcriptional factor that links divergent neurodegenerative disorders Carlson, Kimberly A.
2000
21 S1 p. 119-
1 p.
artikel
824 Necker's cube a new tool in dementia evaluation Fernandez-Viadero, Carlos
2000
21 S1 p. 30-
1 p.
artikel
825 Negligible effects of depression on verbal and spatial performance in Alzheimer's disease Berger, Anna-Karin
2000
21 S1 p. 16-
1 p.
artikel
826 Neotrofin™: Novel approach for Alzheimer's disease treatment Wieland, Scott
2000
21 S1 p. 274-
1 p.
artikel
827 Neural circuits compromised in the aged brain Morrison, John Henry
2000
21 S1 p. 72-
1 p.
artikel
828 Neural representation of nouns in Alzheimer's patients: An fMRI study Koenig, Phyllis
2000
21 S1 p. 40-41
2 p.
artikel
829 Neurochemical and behavioral alterations induced in mice by centrally administered carboxyl-terminal fragment of β-amyloid precursor protein Park, Cheol Hyoung
2000
21 S1 p. 157-
1 p.
artikel
830 Neuroendocrine and cognitive response from testosterone treatment in men with Alzheimer's disease Cherrier, Monique M.
2000
21 S1 p. 61-
1 p.
artikel
831 Neuroendocrine markers of cognition-enhancing efficacy of estrogen in postmenopausal women with Alzheimer's disease Asthana, Sanjay
2000
21 S1 p. 92-
1 p.
artikel
832 Neurofibrillary degeneration: Patterns of tau isoform expression Delacourte, Andre
2000
21 S1 p. 210-
1 p.
artikel
833 Neurofibrillary tangles, neuritic plaques, and cerebrovascular lesions at death among demented and cognitively normal Japanese-American men Petrovitch, Helen
2000
21 S1 p. 57-
1 p.
artikel
834 Neurofibrillary tangles, neuronal loss, and severe motor changes develop in transgenic mice expressing tau (4R0N) with the frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) mutation P301L Lewis, Jada
2000
21 S1 p. 59-
1 p.
artikel
835 Neuroimaging, clinical features and histopathology — A comparison between Lewy body dementia and Alzheimer's disease diagnosed on clinical grounds Londos, Elisabet
2000
21 S1 p. 14-
1 p.
artikel
836 Neuroimaging studies in the oldest old Kaye, Jeffrey A.
2000
21 S1 p. 281-
1 p.
artikel
837 Neuroinflammation and Alzheimer's disease: Relationship between pathogenic mechanisms and clinical expression Eikelenboom, Piet
2000
21 S1 p. 285-
1 p.
artikel
838 Neuroinflammation in Alzheimer's disease Rogers, Joseph B.
2000
21 S1 p. 208-
1 p.
artikel
839 Neuromodulation and neurodegeneration: Toward a comprehensive theory for Alzheimer disease Schmitt, Horst P.
2000
21 S1 p. 142-143
2 p.
artikel
840 Neuronal apoptosis mediated via proinflammatory secretions from β-amyloid stimulated monocytes occurs in a TNFα-dependent fashion Combs, Colin Kelly
2000
21 S1 p. 25-
1 p.
artikel
841 Neuronal expression of human apolipoprotein E4 increases protein tau phosphorylation in transgenic mice Tesseur, Ina C.
2000
21 S1 p. 60-
1 p.
artikel
842 Neuronal plasticity in Alzheimer's disease Mikkonen, Mia
2000
21 S1 p. 113-
1 p.
artikel
843 Neuropathological and behavioral characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice Lamb, Bruce T.
2000
21 S1 p. 224-
1 p.
artikel
844 Neuropathological diagnoses in a community-based incident dementia case series Tsuang, Debby W.
2000
21 S1 p. 191-
1 p.
artikel
845 Neuropathological distinctions and overlap between aging and Alzheimer's disease Price, Joseph L.
2000
21 S1 p. 281-
1 p.
artikel
846 Neuropathological substrate of mild cognitive impairment Petersen, Ronald C.
2000
21 S1 p. 198-
1 p.
artikel
847 Neuropathology of cerebrovascular lesions in dementia Brun, Arne
2000
21 S1 p. 7-
1 p.
artikel
848 Neuropathology of hereditary tauopathies Ghetti, Bernardino
2000
21 S1 p. 69-
1 p.
artikel
849 Neuroprotective actions of estradiol in the adult and aging brain: Potential mechanisms of action Wise, Phyllis M.
2000
21 S1 p. 212-213
2 p.
artikel
850 Neuroprotective effect of dietary restriction involves a stress response and increased expression of neurotrophic factors Lee, J.
2000
21 S1 p. 45-
1 p.
artikel
851 Neuropsychological correlates of early Alzheimer's disease Ferris, Steven H.
2000
21 S1 p. 72-
1 p.
artikel
852 Neuropsychological profiles of familial Alzheimer's disease associated with mutation in the presenilin 1 gene Warrington, Elizabeth K.
2000
21 S1 p. 234-
1 p.
artikel
853 Neuropsychologoical predictors of cognitive decline Welsh-Bohmer, Kathleen A.
2000
21 S1 p. 3-
1 p.
artikel
854 Neuropsychology of normal aging in the nonhuman primate Rapp, Peter R.
2000
21 S1 p. 71-
1 p.
artikel
855 Neurosteroids: Oxidative stress-mediated dehydroepiandrosterone formation in Alzheimer's disease pathology Brown, Rachel C.
2000
21 S1 p. 238-
1 p.
artikel
856 Neurotoxic and fibrillogenic properties of amino-terminally modified amyloid β-peptides Russo, Claudio
2000
21 S1 p. 263-
1 p.
artikel
857 Neurotrophin receptors in Alzheimer brain and A mouse model of down syndrome Salehi, Ahmad
2000
21 S1 p. 114-
1 p.
artikel
858 New possibilities for prevention in dementia Winblad, Bengt
2000
21 S1 p. 215-
1 p.
artikel
859 No association between α2-macroglobulin DNA polymorphism and Italian sporadic Alzheimer's disease Nacmias, Benedetta
2000
21 S1 p. 104-
1 p.
artikel
860 Non-pharmacological coordinated treatment for Alzheimer's disease Zeisel, John R.
2000
21 S1 p. 80-
1 p.
artikel
861 Non-pharmacologic approaches to behavior Gwyther, Lisa P.
2000
21 S1 p. 74-
1 p.
artikel
862 Noradrenergic changes and aggressive behaviour in patients with dementia Matthews, Kim L.
2000
21 S1 p. 229-
1 p.
artikel
863 Normal synaptic plasticity in mice over-expressing a mutant form of human amyloid precursor protein Morton, Robin A.
2000
21 S1 p. 223-
1 p.
artikel
864 Novel differential interaction of TNF receptor subtypes with Alzheimer's amyloid-β-peptide signals neuron death and survival Shen, Yong
2000
21 S1 p. 255-
1 p.
artikel
865 Novel regulation of interaction between APP and its binding proteins Ando, Kanae
2000
21 S1 p. 185-
1 p.
artikel
866 Novel selective butyrylcholinesterase inhibitors as a new strategy for the treatment of Alzheimer's disease Greig, Nigel H.
2000
21 S1 p. 274-
1 p.
artikel
867 N-terminal pyroglutamate enhances the fibrillogenic properties of the ABRI peptide in familial British dementia Miravalle, Leticia
2000
21 S1 p. 84-
1 p.
artikel
868 Nulliparity and late menopause are associated with less age-related cognitive decline Lyketsos, Constantine G.
2000
21 S1 p. 34-35
2 p.
artikel
869 Nursing evaluation at home and in institutionalized elderly suffering from dementia Ferretti, Renata Eloah
2000
21 S1 p. 233-
1 p.
artikel
870 Observations in transgenic mice expressing human wild-type and A30P-mutated α-synuclein Supala, Agnes
2000
21 S1 p. 85-
1 p.
artikel
871 Occupational demands and Alzheimer's disease: A case-control study Cook, Thomas B.
2000
21 S1 p. 170-
1 p.
artikel
872 Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Alzheimer's disease Scott Clark, W.
2000
21 S1 p. 241-
1 p.
artikel
873 Olfactory deficits in mold cognitive impairment predict Alzheimer's disease on follow-up Devanand, Davangere P.
2000
21 S1 p. 271-
1 p.
artikel
874 Olfactory function and event-related potentials in Alzheimer's disease Murphy, Claire
2000
21 S1 p. 271-
1 p.
artikel
875 Oligomeric Aβ affects cell function in NGF-differentiated PC12 cells Rowse, Linda M.
2000
21 S1 p. 13-
1 p.
artikel
876 Oligomeric AB in PBS-soluble extracts of human Alzheimer brain Cherny, Robert A.
2000
21 S1 p. 13-
1 p.
artikel
877 Onset and duration of symptoms in mild cognitive impairment Sano, Mary C.
2000
21 S1 p. 124-
1 p.
artikel
878 Opposing effects of the Aβ peptide and its precursor protein on the proapoptotic P53 pathway Gan, Li
2000
21 S1 p. 184-
1 p.
artikel
879 Ostrogn receptors containing neurons decrease in the hippocampus of Alzheimer patients Zhou, Jiang-Ning
2000
21 S1 p. 264-
1 p.
artikel
880 Overexpression of cyclooxygenase-2 MRNA and protein in the brain of scrapie-infected mice Kim, Jae-Il
2000
21 S1 p. 87-
1 p.
artikel
881 Overexpression of heme oxygenase-1 and ferritin in the brains of scrapie-infected mice Choi, Yeong-Gon
2000
21 S1 p. 151-
1 p.
artikel
882 Overexpression of tau associates with differentiation of neuronal cells in culture Haque, Niloufar
2000
21 S1 p. 110-
1 p.
artikel
883 Overexpression of tau protein inhibits the outward flow of vesicles and organelles along microtubules Stamer, Karsten
2000
21 S1 p. 15-
1 p.
artikel
884 Overproduction of C9 protein the final component of membrane attack complex in the Alzheimer's brain Yang, Li-Bang
2000
21 S1 p. 82-
1 p.
artikel
885 Overview of Alzheimer's disease therapeutics Thal, Leon J.
2000
21 S1 p. 212-
1 p.
artikel
886 Overview of the synucleinopathies Trojanowski, John Q.
2000
21 S1 p. 283-
1 p.
artikel
887 Overview of vascular dementia Markesbery, William R.
2000
21 S1 p. 6-
1 p.
artikel
888 Oxidative stress and mitochondria alterations in Alzheimer's disease Baloyannis, Stavros J.
2000
21 S1 p. 264-
1 p.
artikel
889 Oxidative stress and the calcium stores that are abnormal in fibroblasts from patients with Alzheimer's disease Zhang, Hui
2000
21 S1 p. 116-117
2 p.
artikel
890 Oxidative stress, enzymatic activities and cognitive decline in the EVA study Berr, Claudine
2000
21 S1 p. 64-
1 p.
artikel
891 Oxidative stress induces increase of intracellular a amyloid β-protein and selective activation of PKC βI and βII in NT2 cells Tabaton, Massimo
2000
21 S1 p. 41-
1 p.
artikel
892 Pathobiology of tauopathies: In vitro and in vivo models Lee, Virginia M.-Y.
2000
21 S1 p. 69-
1 p.
artikel
893 Pathogenic mechanisms underlying biogenesis of a β from amyloid precursor protein Masters, Colin L.
2000
21 S1 p. 5-
1 p.
artikel
894 Pathologic effects of amyloidβ deposits in the aged rhesus brain Geula, Changiz
2000
21 S1 p. 122-
1 p.
artikel
895 Pathologies of the nervous system: Epidemiological and clinical research Ritchie, Karen
2000
21 S1 p. 281-
1 p.
artikel
896 Pathology and pathogenesis of prion diseases DeArmond, Stephen Joseph
2000
21 S1 p. 208-
1 p.
artikel
897 Pathology of flemish APP692 Alzheimer's disease suggests that core containing plaques are angiocenteric Kumar-Singh, Samir
2000
21 S1 p. 66-
1 p.
artikel
898 Pathology of Parkinsonism Jellinger, Kurt A.
2000
21 S1 p. 135-
1 p.
artikel
899 Pathway of tau aggregation into Alzheimer paired helical filaments Mandelkow, Eckhard
2000
21 S1 p. 210-
1 p.
artikel
900 Patients of visual variant of alzheimer's disease cannot see subjective contours Hirayama, Kazumi
2000
21 S1 p. 222-
1 p.
artikel
901 Patients with dementia with Lewy bodies copy the interlocking pentagons on the mini-mental state examination less accurately than patients with Alzheimer disease Ala, Thomas A.
2000
21 S1 p. 83-
1 p.
artikel
902 Pattern of presenilin-1 expression during retinoic acid differentiation of SH-SY5Y neuroblastoma cells to a neuronal phenotype Flood, Fiona
2000
21 S1 p. 262-
1 p.
artikel
903 PC7 contributes to the processing of the Alzheimer's βamyloid precursor protein in human cells Lopez-Perez, Elvira
2000
21 S1 p. 96-97
2 p.
artikel
904 Perfusion imaging in the diagnosis of Alzheimer's disease: Clinical-pathological correlations Jagust, William J.
2000
21 S1 p. 131-
1 p.
artikel
905 Pesticides increase risks of cognitive dysfunction; MAAS prospective cohort study Bosma, Hans
2000
21 S1 p. 32-
1 p.
artikel
906 PET, MRI and memory function in a community sample: The Salsa study Jagust, William J.
2000
21 S1 p. 142-
1 p.
artikel
907 Pet studies of striatal pre-synaptic dopamine uptake in dementia with lewy bodies and Alzheimer's disease Hu, XiaSheng
2000
21 S1 p. 149-
1 p.
artikel
908 Pharmacological characterization of neuronal glutamate transport in Alzheimer's disease Scott, Heather Louise
2000
21 S1 p. 10-
1 p.
artikel
909 Pharmacologic management of psychiatric disturbances in very elderly persons with dementia Giron, Maria Stella T.
2000
21 S1 p. 172-
1 p.
artikel
910 Phenomenological dimensions of disinhibition in dementia Kremer, Janus L.
2000
21 S1 p. 27-
1 p.
artikel
911 Phenotypes of A-beta granule-containing glial cells in the brain of Alzheimer's disease Akiyama, Haruhiko
2000
21 S1 p. 149-
1 p.
artikel
912 Phenotypic alterations triggerred by a novel mutation responsible for early onset Alzheimer's disease: A study on βAPP maturation and apoptotic response Checler, Frederic
2000
21 S1 p. 23-
1 p.
artikel
913 Phosphatidic acid increases the fibrillogenesis of amyloid beta-protein by enhancing the growth of fibrils without affecting nucleation phase Chauhan, Ved
2000
21 S1 p. 222-223
2 p.
artikel
914 Phosphorylated tau protein in cerebrospinal fluid is elevated in Alzheimer's disease and other tauopathies Urakami, Katsuya
2000
21 S1 p. 155-
1 p.
artikel
915 Phosphorylation and aggregation of tau protein Avila, Jesus
2000
21 S1 p. 210-
1 p.
artikel
916 Photoactivated, active site directed γ-secretase inhibitors covalently label presenilin 1 Gardell, Stephen J.
2000
21 S1 p. 277-
1 p.
artikel
917 Physical restraints in the care of demented patients Sandman, Per-Olof
2000
21 S1 p. 6-
1 p.
artikel
918 Physiological function of APP processing Beyreuther, Konrad
2000
21 S1 p. 69-
1 p.
artikel
919 P300 in Alzheimer's disease and in primary progressive aphasia: A 3 year follow-up Paci, Cristina
2000
21 S1 p. 78-
1 p.
artikel
920 Plaque-independent, cyclooxygenase-mediated inhibition of synaptic Na+, K+-ATPase activity by amyloid β-peptide Foley, Timothy D.
2000
21 S1 p. 254-
1 p.
artikel
921 Plaque-induced neurite abnormalities in TG2576 HAPPSW over-expressing transgenic mice: Special role of thioflavine S plaques and implications for disruption of the neuropil Hyman, Bradley T.
2000
21 S1 p. 66-
1 p.
artikel
922 Plasma Aβ40 and Aβ42 in Alzheimer's patients during treatment with tacrine Basun, Hans
2000
21 S1 p. 91-
1 p.
artikel
923 Plasma A1-antichymotrypsin in Alzheimer's disease patients and relationships with apolipoprotein E genotypes Gambina, Giuseppe
2000
21 S1 p. 249-
1 p.
artikel
924 Plasma Aβ42 as a diagnostic marker in sporadic Alzheimer's disease Riemenschneider, Matthias
2000
21 S1 p. 272-
1 p.
artikel
925 Plasma and cerebrospinal fluid concentrations of homocysteine are increased in sporadic Alzheimer's disease Gabelli, Carlo
2000
21 S1 p. 127-
1 p.
artikel
926 Plasma antioxidants and oxidative DNA damage in lymphocytes from normal aged people and Alzheimer disease patients Mecocci, Patrizia
2000
21 S1 p. 273-
1 p.
artikel
927 Plasma levels of amyloid β proteins in patients with down syndrome do not predict development of dementia Pirttila, Tuula A.
2000
21 S1 p. 90-91
2 p.
artikel
928 Plasma 24S-hydroxycholesterol (cerebrosterol): An indicator of neuronal degeneration and potential state marker for dementia Papassotiropoulos, Andreas
2000
21 S1 p. 22-
1 p.
artikel
929 Plasma total homocysteine, dementia and mild cognitive impairment Quadri, Pierluigi
2000
21 S1 p. 100-
1 p.
artikel
930 Polymorphisms of the IL-6 gene increase the risk for late onset Alzheimer's disease and affected IL-6 plasma levels Licastro, Federico
2000
21 S1 p. 38-
1 p.
artikel
931 Possible involvement of GSK-3βin regulation of aβmetabolism in the transfected cell lines Sun, Xiaoyan
2000
21 S1 p. 258-
1 p.
artikel
932 Potential for rehabilitation in Alzheimer's disease, by Morris F. Friedell Friedell, Morris F.
2000
21 S1 p. 269-
1 p.
artikel
933 Potentially reversible conditions in memory clinic patients — A prospective study Hejl, Anne-Mette
2000
21 S1 p. 123-
1 p.
artikel
934 Potential role of C/EBP signal transcription in glutamate excitotoxicity and altered glucose utilization in Alzheimer's disease Li, Rena
2000
21 S1 p. 255-
1 p.
artikel
935 Potential roles of the LDL receptor gene family in Alzheimer disease Herz, Joachim
2000
21 S1 p. 5-
1 p.
artikel
936 Practical assessment of an Alzheimer's predictive test in a memory clinic setting: Preliminary findings Iddon, Joanna L.
2000
21 S1 p. 148-
1 p.
artikel
937 Predicting Alzheimer's disease in subjects with cognitive impairment no dementia using the pre-clinical AD scale (PAS) Visser, Pieter J.
2000
21 S1 p. 98-99
2 p.
artikel
938 Prediction of AD using MRI/SPECT Johnson, Keith A.
2000
21 S1 p. 141-
1 p.
artikel
939 Prediction of treatment response with donepezil in Alzheimer's disease Chertkow, Howard Mark
2000
21 S1 p. 24-
1 p.
artikel
940 Prediction of use of emergency community services by cognitively impaired seniors who live alone Tierney, Mary C.
2000
21 S1 p. 276-
1 p.
artikel
941 Predictive factors for the utilization of a memory clinic Kratzsch, Tilman
2000
21 S1 p. 247-
1 p.
artikel
942 Predictors of mortality in dementia patients upon entry into long-term care Carlson, Michelle C.
2000
21 S1 p. 233-
1 p.
artikel
943 Prefrontal activation during deep and shallow incidental encoding of figurative and non-figurative drawings Petersson, Karl Magnus
2000
21 S1 p. 229-
1 p.
artikel
944 Preocupation with bowel functions as an early symptom of Alzheimer's disease Acosta, Daisy M.
2000
21 S1 p. 234-235
2 p.
artikel
945 Presence of short-chain L-3-hydroxyacyl-coa dehydrogenase in amyloid plaques of transgenic mice, but absence in Alzheimer's disease brains Wen, Guang Y.
2000
21 S1 p. 192-
1 p.
artikel
946 Presence of vascular risk factors in ad patients predicts greater response to cholinesterase inhibition Kumar, Vinod
2000
21 S1 p. 218-
1 p.
artikel
947 Presenilin 1 alone is not sufficient to obtain γ-secretase activity in yeast Mastrangelo, Peter
2000
21 S1 p. 68-
1 p.
artikel
948 Presenilin and ER stress in Alzheimer pathgenesis Takeda, Masatoshi
2000
21 S1 p. 71-
1 p.
artikel
949 Presenilin-containing aggresome formation in cholesterol mutant cells Kovacs, Imre
2000
21 S1 p. 185-
1 p.
artikel
950 Presenilin 1 interacts with a neuronal cell adhesion molecule and mediates its intracellular trafficking Annaert, Wim G.
2000
21 S1 p. 133-
1 p.
artikel
951 Presenilin-1 is a component of synaptic and endothelial adherens junctions: Implications for FAD Robakis, N.K.
2000
21 S1 p. 70-
1 p.
artikel
952 Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state Li, Yue-Ming
2000
21 S1 p. 277-
1 p.
artikel
953 Presenilin modulates the activity of dishevelled in the WNT pathway Pollard, Claire L.
2000
21 S1 p. 254-
1 p.
artikel
954 Presenilin mutations in colombian familial and sporadic AD sample Jacquier, Martine
2000
21 S1 p. 176-
1 p.
artikel
955 Presenilin P264L knock-in mutation: Differential effects on abproduction, amyloid deposition, and neuronal vulnerability Siman, Robert
2000
21 S1 p. 118-
1 p.
artikel
956 Presenilin 1 processing in cholesterol mutant cells treated with proteasome inhibitors MacKenzie Ingano, Laura A.
2000
21 S1 p. 188-
1 p.
artikel
957 Presenilin's action on amyloid precursor protein cleavage is mediated through cytoplasmic linker protein 170 Tezapsidis, Nikolaos
2000
21 S1 p. 180-
1 p.
artikel
958 Presenilins alter the posttranslational processing of proteins in the endoplasmic reticulum and golgi Alexander, Morag
2000
21 S1 p. 191-
1 p.
artikel
959 Presenilns regulators of γ-secretase cleavage Golde, Todd E.
2000
21 S1 p. 67-
1 p.
artikel
960 Prevalence of mild cognitive impairment: A population-based study in elderly subjects Hanninen, Tuomo
2000
21 S1 p. 101-
1 p.
artikel
961 Prevalence of prodromal Alzheimer disease Unverzagt, Frederick W.
2000
21 S1 p. 203-
1 p.
artikel
962 Preventing weight loss in Alzheimer's disease Vellas, Bruno
2000
21 S1 p. 78-
1 p.
artikel
963 Preventive effect of Japanese green tea against cognitive impairment in the elderly 2000
21 S1 p. 9-
1 p.
artikel
964 Primary myopathy and accumulation of PRPSC-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation Chiesa, Roberto
2000
21 S1 p. 57-
1 p.
artikel
965 Prion protein abrogates bax-mediated cell death in human primary neuron cultures Bounhar, Younes
2000
21 S1 p. 50-
1 p.
artikel
966 Prion protein interconversions and TSE diseases Caughey, Byron
2000
21 S1 p. 209-
1 p.
artikel
967 Problem behavior, caregiver reactions, and impact among caregivers of persons with dementia Robinson, Karen M.
2000
21 S1 p. 276-
1 p.
artikel
968 Profiles of gene expression in Alzheimer's disease single neurons and tissue homogenates Coleman, Paul D.
2000
21 S1 p. 73-
1 p.
artikel
969 Progession of patients with mild cognitive decline Tsolaki, Magda Ch.
2000
21 S1 p. 26-
1 p.
artikel
970 Progression of cognitive impairment is slower in leukoencephalopathy than in Alzheimer's disease: A clinicopathologic study Crystal, Howard A.
2000
21 S1 p. 202-
1 p.
artikel
971 Progression of hippocampus and corpus callosum atrophy as independent markers of structural disease progression in Alzheimer's disease Hampel, Harald
2000
21 S1 p. 177-
1 p.
artikel
972 Progression of neuropathology in transgenic mice expressing genes linked to familial Alzheimer's disease: APP, PS-1 or both Moussaoui, Saliha
2000
21 S1 p. 19-
1 p.
artikel
973 Progressive brain atrophy on serial MRI in dementia with lewy bodies: A comparison with Alzheimer's disease and vascular dementia O'Brien, John T.
2000
21 S1 p. 130-
1 p.
artikel
974 Progressive changes in amyloid, apolipoprotein-E, synaptic markers and ubiquitin in frontal lobe of prospectively studied elderly humans Wang, Deng-Shun
2000
21 S1 p. 264-
1 p.
artikel
975 Proinflammatory profile of cytokine expression in APPSW transgenic mice Tehranian, Roya
2000
21 S1 p. 112-
1 p.
artikel
976 Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons Van Dorpe, Jo A.
2000
21 S1 p. 87-
1 p.
artikel
977 Proposed mental incapacity law reform in England — What ethical and legal issues arise for demented people and their carers? Jones, Robert G.
2000
21 S1 p. 248-
1 p.
artikel
978 Protective effect of Japanese green tea against cognitive impairment in the elderly Hasegawa, Tohru
2000
21 S1 p. 166-
1 p.
artikel
979 Protein aging hypothesis of Alzheimer disease Orpiszewski, Josef
2000
21 S1 p. 80-
1 p.
artikel
980 720 proteolytic derivatives of Alzheimer β-amyloid precuesor protein accumulate in restricted and unpredicted intracellular compartments in preseniln 1 deficient cells Chen, Fusheng
2000
21 S1 p. 143-
1 p.
artikel
981 Proteolytic processing of the APP gene family members APLP-1 and APLP-2 Eggert, Simone
2000
21 S1 p. 263-
1 p.
artikel
982 Proton magnetic resonance spectroscopy of the hippocampus: Normatization in the elderly Engelhardt, Eliasz
2000
21 S1 p. 41-
1 p.
artikel
983 PRPSC replication, protein folding and misfolding Cohen, Fred E.
2000
21 S1 p. 208-
1 p.
artikel
984 PS1 is a regulatory component of the cadherin/catenin adherens junction system Baki, Lia
2000
21 S1 p. 68-
1 p.
artikel
985 Psychiatric morbidity in a memory clinic Hording, Merete
2000
21 S1 p. 158-159
2 p.
artikel
986 Psychometric tests and glucose metabolism Ihl, Ralf
2000
21 S1 p. 31-
1 p.
artikel
987 Pulse exposure of fetal rats to aluminum maltol affected the axonal transport system Kashiwagi, Yujiro
2000
21 S1 p. 153-
1 p.
artikel
988 Pupil dilation test for Alzheimer's disease Xiang, Zhiqing
2000
21 S1 p. 78-
1 p.
artikel
989 Quality of life of people with dementia and their informal caregivers Corner, Lynne
2000
21 S1 p. 219-
1 p.
artikel
990 Quantification of glial fibrillary acidic protein levels in neocortical regions of elderly Japanese-American men with Alzheimer's disease Ross, George W.
2000
21 S1 p. 193-
1 p.
artikel
991 Quantitative comparison of white matter changes on MRI and histopathology in Alzheimer brains Wahlund, Lars-Olof
2000
21 S1 p. 251-
1 p.
artikel
992 Quantitative diffusion tensor imaging distinguishes hydrocephalus from Alzheimer's Relkin, Norman R.
2000
21 S1 p. 131-
1 p.
artikel
993 Quantitative evaluation of β-secretase cleavage of amyloid precursor protein in the secretory and endocytic pathways Steinhilb, Michelle L.
2000
21 S1 p. 115-
1 p.
artikel
994 Quantitative imaging in preclinical Alzheimer's disease de Leon, Mony J.
2000
21 S1 p. 73-
1 p.
artikel
995 Quantitative neurofilament protein assay in Alzheimer disease cerebrospinal fluid Hu, Yuanyuan
2000
21 S1 p. 228-
1 p.
artikel
996 Raloxifene: Cognitive-enhancing effects for postmenopausal women with AD Baker, Laura D.
2000
21 S1 p. 92-
1 p.
artikel
997 Rapid aggregation of tau protein into Alzheimer-like paired helical filaments reveals a nucleation-elongation mechanism von Bergen, Martin
2000
21 S1 p. 197-
1 p.
artikel
998 Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity? Catani, Marco
2000
21 S1 p. 83-
1 p.
artikel
999 Recent findings in Lewy body dementia Serby, Michael
2000
21 S1 p. 80-
1 p.
artikel
1000 Recognition of non-dementing cognitive impairment of vascular etiology in a memory clinic Galluzzi, Samantha
2000
21 S1 p. 84-
1 p.
artikel
                             1307 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland